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ABSTRACT
Background: Patients with pancreatic or periampullary cancer experience severe 
symptoms and have poor prognosis even after intentionally curative surgery. To 
meet patients’ needs healthcare professionals are required to form partnerships 
with patients. Routine collection and management of symptoms with support of 
mHealth have shown promising results on improved health-related quality of life 
and decreased symptom distress for patients with cancer.
Aim: To evaluate if collection and management of patient-reported outcomes 
in clinical practice, with support of an interactive app (Interaktor), can enable 
person-centered care and improve outcomes for patients who have undergone 
pancreaticoduodenectomy due to cancer.
Methods: Trough Interaktor patients reports symptoms, which are monitored 
and responded to by clinical nurses. In the app patients can also view graphs over 
their previous reports and read self-care advice. The Medical Research Council’s 
framework for complex interventions was used to develop and evaluate the app. In 
Phase I the content in the app was developed by interviews with patients (n=14) 
and healthcare professionals (n= 10). In Phase II the app was tested for feasibility 
by patients (n=6) during one month. In Phase III the app was evaluated by analyz-
ing the impact of symptoms and self-care activity in patients (n=26) using the app 
for six months, compared with a historical control group of patients (n=33) not 
using the app, by analysis of patients’ (n=26) logged data in the app, and through 
interviews with patients (n=25) using the app.
Results: The results in Phase I contributed to knowledge on important symptoms 
to assess and some self-care advice and strategies to manage these symptoms 
which formed the content in the Interaktor app. The results in Phase II showed 
that the app was feasible and had relevant content. The patients felt reassured and 
taken cared of at home and got support for symptom management. The results in 
Phase III showed that using the app decreased symptoms and increased self-care 
activity after pancreaticoduodenectomy. Further, patients using the app had high 
adherence to report symptoms as intended, and felt that they could have their 
voices heard trough the app, and that they had an extended arm to healthcare and 
learned about their own health.
Conclusion: The thesis shows that an interactive app like Interaktor can support 
patients with severe symptoms and poor prognosis. Person-centered care can be 
enabled by making the patients active partners in care and by timely identification 
of symptoms important to patients.
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11 INTRODUCTION
When writing my master thesis, which concerned assessments to find early signs 
of complications after pancreatic surgery, I found that the patients’ judgements of 
their general health could predict an upcoming complication just as well as objec-
tive signs. My conclusion was that for this vulnerable group of patients, their own 
health assessments should be included in the postoperative assessments. At that 
time the clinic where I was working (and still do), was focusing on supporting 
patients’ self-care ability based on needs attributed to their disease or treatment. 
The concept of person-centered care and incorporating the patient’s narrative in 
the care plan was not yet established. Since I wanted to continue to explore how 
the patients’ voices could be more incorporated in clinical care, I got in contact 
with the newly installed professor of nursing at Karolinska Institutet. She shared 
her ideas about an interactive mobile app, later called Interaktor, where patients 
would self-report symptoms that were acted upon by healthcare professionals. 
I instantly felt that her views of a model where care was given in collaboration 
with fully active participating patients was just what I was looking for. Since the 
idea with the interactive app was to make patients participate in care by reporting 
symptoms, interact with nurses and have access to self-care advice, the app was 
considered to be complex. At that time the Medical Research Council in UK had 
just authored their updated framework for development and evaluation of com-
plex interventions. The framework was found to be suitable for developing and 
evaluating the app and that is how this doctoral project was initiated.
My hope is that the findings will contribute to a care system where the needs of 
patients with pancreatic cancer are known to and supported by healthcare profes-
sional even when patients are at home. Further, I hope that care will be based on 
patients’ individual needs rather than the needs of the healthcare organization. 
22 BACKGROUND
2.1 Pancreaticoduodenectomy and cancer
In Sweden, 1500 individuals, equally distributed between men and women, are 
diagnosed each year with cancer in the pancreas or periampullary region, the 
 latter includes the duodenum, extrahepatic bile ducts and the ampulla of Vater. 
The disease is associated with vague and unspecific symptoms and is therefore 
often diagnosed at an advanced stage, which contributes to patients mostly being 
offered different types of palliative treatments. The disease has poor prognosis and 
only about 8 percent of patients are alive 5 years after receiving their diagnose, 
regardless of treatment (The National Board of Health and Welfare & The Swedish 
Cancer Society, 2018) . The only hope for cure is surgical resection, which can be 
offered to less than 20% of the patients (Kleeff et al., 2016). After surgery eligible 
patients are offered adjuvant chemotherapy. Even after intentionally curative sur-
gery and adjuvant chemotherapy the prognosis is poor, with a median survival of 
2 and 4 years in pancreatic and periampullary cancer respectively (Neoptolemos 
et al., 2012; Neoptolemos et al., 2010). Most resectable tumors are located in the 
head of the pancreas or periampullary region and for these the standard treatment 
is pancreaticoduodenectomy (PD). The surgery includes removal of the pancreatic 
head, duodenum, distal common bile duct and gall bladder, with or without pre-
serving the gastric antrum and pylorus (Pappas, Krzywda, & McDowell, 2010). 
In addition to those with pancreatic and periampullary tumors, PD is also offered 
to patients with neuroendocrine tumors (NET) and intraductal papillary mucinous 
neoplasm (IPMN), which can either be premalignant or carry invasive cancer. 
The recovery period can be long and problematic, since half of patients will suffer 
from postoperative complications such as delayed gastric emptying, pancreatic 
fistula, abdominal abscess, wound infection or cardiopulmonary problems (Winter 
et al., 2006). Furthermore, quality of life is reported to be considerably impaired 
after PD but is gradually regained within the first 6 to 24 months (Chan et al., 
2012; Gerstenhaber et al., 2013; Kostro & Sledzinski, 2008; Nieveen van Dijkum 
et al., 2005; Pezzilli et al., 2011; Schniewind et al., 2006). After surgery, patients 
usually experience symptoms like pain, fatigue, diarrhea and appetite loss (van 
Dijk et al., 2018). Patients describe how the symptoms can lead to social isolation, 
but they can be managed using self-care strategies as well as support from their 
families (Andersson, Falk, Bjerså, & Forsberg, 2012; Carey, Laws, Ferrie, Young, 
& Allman-Farinelli, 2013). However, after PD patients sometimes have inadequate 
strategies to manage symptoms. One example is the lack of knowledge about how 
to prevent malnutrition and diarrhea by taking pancreatic enzyme supplements 
with every meal (Carey et al., 2013). Also, patients may resign to their symptoms 
and are therefore unlikely to complain, which requires a healthcare system where 
professionals are more vigilant for symptoms (Carey et al., 2013). In fact, patients 
3have expressed experiences of no longer feeling cared for, lack of someone to dis-
cuss symptoms and self-care strategies with, and have underlined the importance 
of support from healthcare professionals even after discharge (Andersson et al., 
2012). Unmet supportive care needs, especially of a physical and psychological 
nature, but also regarding information from the healthcare system, are prominent 
in patients affected by pancreatic cancer. It has been concluded that future research 
and efforts need to focus on changing the healthcare system and services so that 
these needs are met (Beesley et al., 2016). 
2.2 Person-centered care
To achieve the best care for patients with advanced cancer, the integration of a 
disease- specific approach and focus on the person behind the disease are vital 
components (Kaasa et al., 2018). Within nursing, the concept of person-centered 
care is visible even in the work of Florence Nightingale (1860) who distinguished 
nursing from medicine by focusing on the sick person rather than the disease. A 
person-centered approach was early described as central in caring for another 
person and emphasized as an understanding of a person’s perspective and experi-
ence of a situation. Further, each person was theorized to be able to draw strength 
from available resources and find a way to aid difficulties as long as a facilitating 
environment is present (Rogers, 1961). Within the frame of person-centered care 
the use of the term person instead of patient are suggested to clarify the focus on 
the needs and preferences of the person and not solely the disease (Kristensson 
Uggla, 2015). However, it has been argued that it is still relevant to use the term 
patient when discussing person-centered care to clarify the patients role as sepa-
rate from the healthcare professionals legal obligations (Kristensson Uggla, 2015). 
Therefore, the participating patients throughout this thesis are referred to as patients.
Person-centered care emphasizes the patients’ perspective and involvement, result-
ing in a shift from a model where patients are objects of care to a model where the 
patient is involved as an active partner in their own care and the decision-making 
process (Leplege et al., 2007). Patients’ involvements in care has been stipulated 
in Swedish law, which states that patients should be given the opportunity to par-
ticipate in their own health management with a focus on decision making (The 
Swedish Riksdag, 2014). For patients to be active participants in the decision-
making process they need to have sufficient and relevant knowledge which can 
only be provided by continuous person-centered information (Kaasa et al., 2018). 
This requires interactions with healthcare professionals where patients’ needs and 
whishes are systematically assessed (Kaasa et al., 2018).
Aside from partaking in the decision-making process, patient participation has been 
described to also include; mutual communication with healthcare professionals 
where patients are listened to and their knowledge is respected; shared knowledge 
4where patients get explanations for symptoms and procedures and also can tell 
professionals about their symptoms; and patients knowing how to manage their 
symptoms and provide self-care (Eldh, Luhr, & Ehnfors, 2015). To achieve patient 
participation in nursing care the relationship between the patient and the nurse 
is crucial. A relationship which requires time to grow stronger, and the patients 
situation should be considered a source of information that can be transferred into 
knowledge and understanding (Angel & Frederiksen, 2015).
Even though the notion of person-centered care has been a paradigm shift in 
healthcare and especially in nursing during the last decades, patients are still 
navigated through a healthcare system that is adapted to the routines and needs of 
organizations and professionals, rather than focusing on the individual patient’s 
needs, preferences and values (Ekman et al., 2011). To shift focus, the patient’s 
narrative must lay the ground for the partnership in care, which focuses on the sick 
person’s experiences of his/her illness, symptoms and impact on daily life. To ask 
for a patients narrative means that their experiences, feelings, beliefs, preferences, 
and resources for self-care are important for consideration and the shift from the 
disease to the person with the illness can be enabled (Ekman et al., 2011). The 
implementation of different types of person-centered care approaches in Swedish 
care facilities have been evaluated and shown to reduce hospital stays and healthcare 
costs (Ekman et al., 2012; Hansson et al., 2016), a more welcoming environment 
and improved working environments (Edvardsson, Sandman, & Borell, 2014). 
In the out-patient setting the health-related quality of life (HRQoL) increased 
while symptoms were reduced (Brännström & Boman, 2014; Feldthusen, Dean, 
Forsblad-d’Elia, & Mannerkorpi, 2016), disease control improved (Jutterström, 
Hornsten, Sandström, Stenlund, & Isaksson, 2016) and self-efficacy increased (Fors 
et al., 2018). Most studies have been focusing on care for patients with chronic 
conditions such as dementia, heart failure, chronic obstructive pulmonary disease, 
diabetes and rheumatoid arthritis while few include patients with severe cancer 
diagnosis. Patients with head and neck cancer, who had a clinical meeting with a 
nurse before start of treatment where a person-centered care plan was designed, 
showed decreased disease-related symptoms during treatment compared to a control 
group (Hansson, Carlström, Olsson, Nyman, & Koinberg, 2017). There is a need 
for knowledge on how the patient’s narrative can be continuously incorporated 
in the care process when patients with severe cancer diagnosis are cared for at 
a distance, namely as out-patients. One way can be to make the patients’ voices 
heard by assessing patient-reported outcomes in clinical care, such as health-related 
quality of life, including symptoms and functions (Kaasa et al., 2018). Further, 
for healthcare professionals to establish partnership with patients and thereby 
enable realistic goals to be drawn up in care plans, enhancing patients self-care is 
required (McCorkle et al., 2011).
52.3 Self-care 
Self-care was introduced as an element of nursing by Dorothea Orem who theo-
rized that self-care is a learnt human behavior and a conscious, deliberate and 
self-initiated action that the individual performs in daily life (Orem, Taylor, & 
Renpenning, 2001). Every person has the ability and motivation to perform actions 
to promote their own health, wellbeing and personal development and to prevent 
sickness. Preconditions for self-care are that the person is mature and has devel-
oped abilities to take care of oneself in the environment and situation in which he/
she lives. To be able to perform self-care, a person needs to have  knowledge and 
understanding of what the actions mean (Orem et al., 2001). A closely related term 
to self-care is self-management. Self-management has been defined as “those tasks 
that individuals undertake to deal with the medical, role and emotional manage-
ment of their health condition” and strive to help patients to take an active role in 
preventing and managing symptoms, during and after treatment (McCorkle et al., 
2011). The terms self-care and self-management are often used interchangeably 
(Peeters, Wiegers, & Friele, 2013) and sometimes in combination, namely self-
care management (Hammer et al., 2015). Similarly defined self-care and self-
management include tasks, skills, and competences used to cope with an illness 
and its integration on a person’s life (Peeters et al., 2013). 
In today’s cancer care, with shortened hospital stays and treatments given at out-
patient units and where cancers in many cases are considered to be long-term con-
ditions, patients are expected to shoulder a greater role in managing consequences 
of treatment and everyday life (McCorkle et al., 2011). When patients with cancer 
were asked about their attitudes towards self-care, a majority reported a positive 
attitude in their ability to take own actions to improve their health (Jansen, van 
Uden-Kraan, van Zwieten, Witte, & Verdonck-de Leeuw, 2015). Nevertheless, about 
half of the patients felt unable to judge whether their symptoms were serious and 
only a small part were positive towards controlling their own health rather than 
visit a physician (Jansen et al., 2015). Nursing interventions to enhance self-care 
for patients with cancer have been focusing on relieving symptoms and improving 
quality of life by education, counseling, exercise, or complementary and alterna-
tive medicine therapies (Hammer et al., 2015). Many interventions have shown 
favorable outcomes and positive trends, such as improved overall quality of life 
and symptom management. However, findings have rarely shown statistical sig-
nificance (Hammer et al., 2015). Using the internet to get advice on how to handle 
or cope with own illness or to monitor symptoms has been perceived as positive 
by patients with cancer (Jansen et al., 2015). 
62.4 Patient-reported outcomes
A patient-reported outcome (PRO) is defined as any report of the status of a patient’s 
health condition that comes directly from the patient, without interpretation by a 
clinician or anyone else. A PRO can be measured in absolute terms, for instance 
severity of a symptom or as a change from a previous measure (U.S. Department 
of Health and Human Services FDA, 2006). Self-reported assessments of HRQoL, 
including symptoms and functional status, are grouped under the umbrella term 
patient-reported outcome measures (PROM) (Kaasa et al., 2018). 
The term HRQoL is often used in clinical trials to distinguish between general 
senses of quality of life. Hence, the term also comprises symptoms and func-
tions that are affected or not affected due to an illness (Fayers & Machin, 2007). 
There are many questionnaires that assess HRQoL, some instruments intended 
for  general use, irrespective of a patient’s illness or condition, and some disease-
specific instruments used to detect differences that arise as a consequence of specific 
treatments or interventions (Fayers & Machin, 2007). It has been noted that quality 
of life measurements are not always sensitive enough to detect changes during 
a symptom-management intervention as compared to measurements of patients’ 
symptom experiences (Molassiotis et al., 2009). Further, while symptom burden 
decrease over time for patients with cancer, quality of life has been found to be 
stable (Deshields, Potter, Olsen, & Liu, 2014). A symptom has been defined as an 
individual’s subjective experience of changes in functions, feelings or perceptions 
and cannot be objectively identified (Dodd et al., 2001). The symptom experience 
can be described in several dimensions, such as prevalence, frequency, severity, 
bother, intensity and distress (Henoch, Olsson, Larsson, & Ahlberg, 2018). To 
assess a patient’s frequency, severity and distress of a symptom has been shown to 
be valuable measurements both in research and clinical settings (Browall, Kenne 
Sarenmalm, Nasic, Wengström, & Gaston-Johansson, 2013). However, there is no 
consensus as to which dimensions affect patients’ well-being the most and thereby 
which data best to collect, when evaluating interventions to improve patients symp-
tom experience (Henoch et al., 2018). Patients with cancer, cared for as outpatients, 
often experience multiple symptoms and if these are not identified and managed 
they will impact the patient’s HRQoL and recovery (Pachman, Barton, Swetz, & 
Loprinzi, 2012). Symptom management is a key element in supporting care of 
patients with advanced cancer (Kaasa et al., 2018). Recent recommendations are 
that patients with pancreatic cancer are offered thorough symptoms management 
and advance care planning at an early stage of their illnesses (Rabow, Petzel, & 
Adkins, 2017). Even so, symptom assessments are rarely systematically collected 
and routinely incorporated in clinical cancer care (Kaasa et al., 2018).
Evidence suggests that using PROM as a routine in clinical practice can facilitate 
detection of symptoms and concerns, enhance communication between patients 
and healthcare professionals regarding experienced and distressing symptoms, 
7inform on impact of treatment, promote shared decision making, and improve 
patient satisfaction (Howell et al., 2015; Kotronoulas et al., 2014; Valderas et al., 
2008). Traditionally, PROM have been collected through paper-based question-
naires, but the rapid advancements in information and communication technology 
has promoted the development of electronic tools (Kaasa et al., 2018). Thereby, 
there are possibilities to create new care models in which PROM can be integrated 
and patients monitored at a distance (Kaasa et al., 2018). 
2.5 Information and communication technology
Modern information and communication technologies (ICT) are believed to enable 
patient participation in own care and to support contact between patients and 
healthcare (Swedish Government & Swedish Association of Local Authorities, 
2016). The use of ICT for health is described under the term eHealth by the World 
Health Organization, and when ICT are mobile and wireless they are described 
as mHealth (World Health Organization, 2011). mHealth has the potential to 
change the delivery of healthcare due to the rapid advances in mobile technolo-
gies, the improvements in possibilities to integrated mHealth into existing eHealth 
services, and the growing mobile coverage (World Health Organization, 2011). 
The growing mobile coverage is evident in Sweden as 94% of households now 
have internet access (European Union, 2016). Also, 85% have reported to use the 
internet daily and over 64% are using the internet to search for information on 
health (European Union, 2016). This shows the interest of using eHealth in the 
Swedish population. In 2016 the Swedish Government and the Swedish Association 
of Local Authorities and Regions jointly decided on a vision for eHealth policy 
(Swedish Government & Swedish Association of Local Authorities, 2016). The 
vision is that by 2025, Sweden aims to be the best country in the world at using 
the opportunities offered by digitalization and eHealth in both health and welfare 
to achieve a good and equal health amongst individuals and to enhance their own 
resources for increased independence and participation (Swedish Government & 
Swedish Association of Local Authorities, 2016). It is important to bring this goal 
into clinical healthcare and nursing through new eHealth solutions that enable 
person-centered care.
Promising results are beginning to show that mHealth can support patients with 
chronic conditions in participating in their own health and in making them feel 
secure and taken care of even outside the hospital (Wang et al., 2014). Using 
mHealth to deliver different self-care interventions to patients with long-term con-
ditions, like motivating and advisory automatic messages connected to a reported 
symptom or disease-related sign, show a potential to improve patients’ symptom 
management (Whitehead & Seaton, 2016). However, these evaluated self-care 
interventions have not targeted patients with cancer, and most have not provided 
real-time interactions with healthcare professionals (Whitehead & Seaton, 2016).
8It has been proven to be feasible and a well-accepted method to offer patients 
with cancer undergoing treatment to interact with healthcare professionals by self-
reporting symptoms via different kinds of eHealth systems (Basch et al., 2007; 
Denis et al., 2014; Judson et al., 2013; McCann, Maguire, Miller, & Kearney, 2009; 
Sundberg, Eklöf, Blomberg, Isaksson, & Wengström, 2015; Weaver et al., 2014). 
Common for these systems is that patients regularly submit reports between planned 
hospital visits and predefined alerts are immediately sent to either a nurse or an 
oncologist who then respond by contacting the patient. Studies are now showing 
that eHealth systems where patients report symptoms which are then discussed 
at their next hospital visit are effective in terms of fewer visits to the emergency 
room, patients staying on chemotherapy for a longer period (Basch et al., 2016), 
less symptom distress, fewer symptoms in need of symptom management support 
over time (Ruland et al., 2010), improved HRQoL and one year survival (Basch 
et al., 2016; Denis et al., 2017) compared to patients not using such systems or 
where reports were not discussed at visits. Patients in these studies have had a wide 
range of cancer diagnoses, namely; breast, colorectal, genitourinary, gynecologic, 
lung, lymphoma, prostate or multiple myeloma. Also, some evidence exists that 
when patients are also offered written feedback comprising of self-care advice, 
patients feel more in control and confident in their abilities to self-manage their 
illnesses (Weaver et al., 2014), and symptom burdens can be reduced (Kearney 
et al., 2009; Sundberg et al., 2017). 
In summary, there are indications that collecting PRO for regular use in clinical 
care enhance patient participation, lessen symptom burden, increase HRQOL 
and even survival for patients with cancer. Further, most studies have been per-
formed during the period of active treatment while only a few during follow-up, 
which affects the possibility to understand how using mHealth care contributes 
to the creation of new care models throughout the whole cancer continuum (Nasi, 
Cucciniello, & Guerrazzi, 2015). 
93 RATIONALE
Patients with pancreatic or periampullary cancer have poor prognosis even after 
intentionally curative surgery. The surgery usually results in severe symptoms and 
impaired quality of life for a long time. Patients have reported that they often lack 
sufficient knowledge about how to manage their illnesses and that they experience 
unmet supportive care needs. Hence, innovations where these patients can com-
municate with healthcare professionals and get support for self-care are needed. 
By routinely collecting PRO in clinical practice, early detection of symptoms 
can be facilitate, communication between patients and healthcare professionals is 
enhanced, information on impact of treatment is improved, shared decision making 
is promoted, and patient satisfaction is improved. In today’s cancer care, patients 
themselves must shoulder a great role in managing consequences of treatment and 
everyday life. To be able to do so, patients need to have knowledge and understand-
ing about self-care, which requires healthcare professionals to form partnerships 
with patients. Using mHealth has shown promising results in supporting patients 
with cancer to participate in their own health management. Further, promising 
results on improved HRQoL, decreased symptom distress, fewer symptoms in need 
for symptom management and improved one year survival have been shown after 
routinely reporting symptoms to healthcare with support of mHealth. However, 
only a few of evaluated systems where PROs are collected comprise written self-
care advice. Based on previous research, it is reasonable to believe that routine 
collection and management of relevant patient-reported symptoms can enable 
person-centered care for patients with pancreatic- and periampullary cancer since 
it makes patients active participants in their own care. Also, supportive care needs 
can be identified for the right patient at the right time.
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4 AIM
The overall aim of the thesis is to evaluate if collection and management of 
patient-reported outcomes in clinical practice, with support of an interactive app 
(Interaktor), can enable person-centered care and improve outcomes for patients 
who have undergone pancreaticoduodenectomy due to cancer.
Study I
With the goal of developing the content of the interactive ICT application, the aim 
was to explore common symptoms and self-care in the first six months after pan-
creaticoduodenectomy, as identified by patients who have undergone this surgery 
and by healthcare professionals caring for these patients.
Study II
The aim was to develop and test a version of the Interaktor app adapted for patients 
who have undergone pancreaticoduodenectomy.
Study III
The aim was to evaluate the impact on health-related quality of life and self-care 
activity when using the Interaktor app following pancreaticoduodenectomy due 
to cancer.
Study IV
The aim was to describe how patients following pancreaticoduodenectomy due to 
cancer have used Interaktor and their experiences of using it.
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5 METHODS
5.1 Design
The study design is underpinned by the Medical Research Council’s (MRC) com-
plex intervention evaluation framework (Craig et al., 2008). An intervention can 
be considered to be complex if several interacting components exist, if several and 
difficult behaviors are required by those involved, if several groups or organiza-
tions are involved, if several and variable outcomes are being aimed at, and if 
the intervention are tailored yet flexible (Craig et al., 2008). The intervention 
in this thesis can be considered complex as multiple components are involved 
which require active engagement from patients and healthcare professionals. The 
components include the technology where patients send reports on symptoms to 
the hospital while being at home, the automatically triggered alerts to healthcare 
professionals, the suggestions to view self-care advice and the possibility for 
healthcare professionals to view patients’ reports. The MRC framework initially 
includes three phases; 1) developing the intervention, 2) assessing feasibility and 
3) evaluating the intervention (Craig et al., 2008). The different phases represent 
the studies included in this thesis (Table 1).
The timeline for the data collection of the studies included in the thesis is pre-
sented in Fig. 1. 
Figure 1. Timeline showing the data collection throughout the studies included in the thesis.
Study I
2012-2013
Study III
2012-2014
•Creating content
for Interaktor
•Interviews with
patients
•Interviews with
healthcare
professionals
•Searches in the
literature
Study II
2013-2014
•Data collection in
control group
•Standard care
•Questionnaires
before surgery
and 6 weeks and
6 months after
surgery
Study III, IV
2015-2017
•Data collection in
feasibility group
•Standard care
•Interaktor for 
4 weeks
•Data collection in
intervention
group
•Standard care
•Interaktor for 
6 months
•Questionnaires
before surgery
and 6 weeks and
6 months after
surgery
•Interviews after
ceasing to use
Interaktor
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Table 1. Overview of the phases in the Medical Research Council’s framework and the studies in the thesis
Framework 
phase
Study Design Sample Data Collection Data analysis
I I Qualitative descriptive Patients (n=14) 
Healthcare  
professionals (n=10)
Semi-structured individual 
interviews and focus groups
Qualitative content analysis
II II Qualitative and quantitative 
descriptive
Patients (n=6) using 
Interaktor (feasibility 
group) 
Nurse (n=1)  monitoring 
alerts
1) Semi-structured indi-
vidual interviews
2) Logged data in the app
1) Qualitative  content analysis
2) Descriptive statistics
III III Quasi-experimental and 
quantitative descriptive
Patients (n=33) receiving 
standard care (control 
group)
Patients (n=26) receiving 
standard care and using 
Interaktor (intervention 
group)
1) Descriptive data, SOC-
13, EORTC QLQ-C30, 
EORTC QLQ-PAN26, 
ASA-A 
2) Logged data in the app
1) Descriptive statistics, t-test, 
Chi-Square-test, Fishers 
Exact Test, Repeated 
measures ANOVA, multiple 
regression 
2) Descriptive statistics
IV Quantitative and qualitative 
descriptive
Patients (n=26) receiving 
standard care and using 
Interaktor (intervention 
group)
1) Data logged in the app
2) Semi-structured indi-
vidual interviews (n=25)
1) Descriptive statistics
2) Qualitative thematic analysis
SOC = Sense of Coherence, EORTC QLQ = European Organization for Research and Treatment on Cancer Quality of Life Questionnaire, ASA = 
Appraisal of Self-care Agency, ANOVA = Analysis of Variance
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5.2 Setting and standard care
Pancreatic surgery at Karolinska University Hospital is performed at a highly spe-
cialized unit regarded as a high-volume center with more than hundred pancreatic 
resections annually. At the time of the studies, the patients met a surgeon, a contact 
nurse, a physiotherapist, an anesthesiologist and a dietician before surgery to gain 
information about the operation and postoperative care. The patients were given 
written information regarding pain treatment, physiotherapy and dietary advice 
including instructions about pancreas enzyme supplements. Following PD, the 
patients were cared for on a surgical ward for 1-2 weeks. Thereafter, if needed, 
care at a rehabilitation unit was offered for up to one week. If the patients had 
questions after discharge, they were encouraged to call their contact nurse at the 
surgical outpatient unit during working hours (8 a.m. to 4 p.m. on weekdays). If in 
need of emergency care they were asked to contact the nearest emergency depart-
ment. Approximately one month after discharge, the patient met with a surgeon 
and sometimes a nurse and/or a dietician. At this out-patient visit the patients were 
informed about the microscopic examination of the tumor and a decision were 
taken whether to offer adjuvant chemotherapy or not. Patients eligible for adjuvant 
chemotherapy began their treatment within 10 weeks after surgery. Chemotherapy 
was given at the oncology clinic once a week for 3 of every 4 weeks (1 cycle) for 
6 months, i.e. 6 cycles in total. During chemotherapy, the patients regularly met an 
oncology nurse and, on some occasions, an oncologist and/or a dietician. Between 
treatments the patients could call either their contact nurse at the oncology depart-
ment or outside working hours, contact the nearest emergency department if needed.
5.3 The Interaktor app
The Interaktor app was developed in co-operation with Health Navigator, a Swedish 
company specializing in healthcare management and new innovative care solutions. 
The content of Interaktor is generic and adjustable depending on setting and situ-
ation. Simultaneously with the work throughout this thesis, additional versions of 
Interaktor adapted for patients with prostate cancer undergoing radiotherapy and 
older people receiving home-based healthcare have been developed and evaluated. 
Therefore, development of Interaktor has been made throughout the whole project 
according to results from studies included in this thesis but also from evaluation 
of versions adapted for other settings and situations (Algilani, Langius-Eklöf, 
Kihlgren, & Blomberg, 2017; Göransson et al., 2018; Hälleberg Nyman et al., 
2017; Langius-Eklöf et al., 2017; Sundberg et al., 2015; Sundberg et al., 2017).
Interaktor can be downloaded onto smartphones or tablets and requires a separate 
individual log in. The components are 1) regular assessment of self-reported symp-
toms and problems, 2) a risk assessment model for alerts on frequent or distressing 
symptoms 3) continuous access to evidence-based self-care advice and links to 
relevant websites for more information, and 4) graphs for the patients to view a 
history of their symptom reporting (Fig. 2). 
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The structure of the symptom assessment is inspired by a standardized symptom 
questionnaire, and patients are first asked about the occurrence of the symptom, 
and then they are asked to rate the frequency and the distress level of the symptom 
(Browall et al., 2013; Portenoy et al., 1994). For example, if the answer to the 
question “Have you had trouble eating in the past day?” is “yes”, the patient would 
be asked how often it occurs (almost never, sometimes, often, or almost always) 
followed by how distressing the symptom is (not at all, a little, rather much, or very 
much). After completing the symptom assessment, the report is immediately sent 
to a secure server that is linked to a web-interface. The server is approved by The 
Swedish Data Protection Authority. In Interaktor, the patient can view the reports 
over time in graphs, and through the web-interface healthcare professionals can 
Figure 2. Screenshots from the Interaktor app adapted for patients following pancreaticoduo-
denectomy showing the main components 1) symptom reporting, 2) alerts, 3) self-care advice 
to read and 4) graph over a symptoms change during the last week.
4. Visualization
2. Alert1. Reporting 3. Self-care
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monitor the reports. The patients have continuous access to self-care advice related 
to the assessed symptoms. Through the self-care advice, the patients, if in need for 
more information, also have access to hyperlinks to websites considered by the 
research group to be evidence-based. If the risk assessment model triggers an alert 
the patients gets suggestions about suitable self-care advice to read. If an alert is 
triggered, a text message (SMS) is sent to a mobile phone at the clinic where the 
alerted symptoms are viewed in the web-interface. Actions taken after alerts can 
be documented in the web-interface. There were two kinds of alerts included in 
the app – yellow and red. A yellow alert indicates that the patient should be con-
tacted the same day. In case of a red alert, the priority is higher, and contact should 
be initiated by the healthcare professional (in this thesis a nurse) within an hour. 
Results from evaluating a version of Interaktor for use during radiotherapy for 
prostate cancer showed that the patients sometimes actively adjusted their symptom 
reporting to avoid an alert and a call from the nurse (Langius-Eklöf et al., 2017). 
Therefore, in the first version of Interaktor adapted for patients who have under-
gone PD (Study II) the SMS-component was changed whereby in case of an alert 
the patients receive a question asking whether they wanted to be contacted by a 
nurse. If choosing “yes”, an automatic SMS would be sent to a nurse. If choosing 
“no”, an SMS was not sent to the nurse, but the alert would still be visible to the 
nurse in the web-interface. An illustration of the idea with the Interaktor app and 
the connected web-interface are shown in Fig. 3.
Figure 3. Illustration of the idea with the Interaktor app and the connected web-interface.
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5.4 Phase I – Development of Interaktor pancreas 
 version (Study I)
5.4.1 Sample
Over a period of six months in 2012 and 2013, all patients who had undergone 
PD at Karolinska University Hospital due to suspected cancer were screened for 
eligibility. Inclusion criteria involved having been discharged from surgery within 
the last six months, being Swedish-speaking, having no cognitive impairment and 
living in the Stockholm area. Previous conclusions have been made that a sample 
of 12 participants are enough to gain knowledge of common experiences in a rela-
tively homogeneous sample (Guest, Bunce, & Johnson, 2006). After stratification 
for equal sex distribution, 14 patients were invited and all consented to participate 
in the study. Further descriptive data are shown in Table 2.
Table 2. Descriptive data of participating patients (n=14) in Study I
Descriptive data
Age in years, mean (median, range) 65 (63, 49-69)
Months since surgery, median (range) 6 (1-7)
Histopathology of tumor, n (%)
    Ductal adenocarcinoma 6 (43)
    Periampullary adenocarcinoma 6 (43)
    Invasive IMPN 2 (14)
Ongoing or completed adjuvant chemotherapy, n (%) 5 (36)
IPMN = intraductal papillary mucinous neoplasm
A purposeful sample of 12 healthcare professionals was invited to participate in 
two focus groups. The inclusion criterion was that they should represent all pro-
fessions in contact with the current patient group in connection to the surgery. For 
all professions, the persons at the site with the longest experience in caring for 
the patient group were invited. At the time of the focus group interviews, three of 
the participants who had been invited were unavailable, and one of them agreed 
to be interviewed individually instead, which resulted in a final sample of 10; 
registered nurse (n=4) including one contact nurse, enrolled nurse (n=2), physio-
therapist (n=2), surgeon (n=1) and dietician (n=1). Their experience of caring for 
the patient group ranged 2-20 years. No medical social worker could participate 
either in the focus groups or in an individual interview.
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5.4.2 Data collection
Interviews were chosen as a data collection method to get insight on patients 
perspectives, feelings and thoughts (Patton, 2015). To get a wide view of experi-
ences patients were interviewed at different time points. The interviews followed 
an interview guide to cover relevant areas (Kvale & Brinkmann, 2009). Questions 
in the guide were: Which symptoms have you experienced at home after surgery? 
How do you deal with these symptoms? What advice have you received from 
healthcare professionals? Do you wish to receive advice about self-care, or do 
you prefer to receive help from someone else? Probing questions were used when 
needed to get a deeper understanding (Patton, 2015). Seven patients were inter-
viewed in connection with a follow-up appointment at the outpatient unit, six at 
home, and one over the phone. The interviews with patients were performed by 
the author of this thesis (n=11) or a researcher with experience of interviewing 
people with cancer (n=3). The interviews lasted on average 40 minutes (range 
19-60 minutes), and were audio recorded and transcribed verbatim by the author 
of the thesis (n=9) or an external transcriber (n=5). All transcripts were checked 
against the audio recording. 
The focus group interviews with healthcare professionals were conducted at the 
hospital where they worked and were facilitated by a moderator and an observer 
not known to the healthcare professionals. Focus group interviews were chosen 
as they take advantage of group dynamics in order to access rich information in 
an efficient manner (Kitzinger, 1994). The individual interview was conducted by 
telephone with the surgeon who could not participate in either focus group. All 
interviews followed an interview guide which contained the following questions: 
What is your impression of how patients experience their life situation after pan-
creaticoduodenectomy? Which symptoms follow pancreaticoduodenectomy? 
Which self-care advice do you give regarding the different symptoms? Probing 
questions were used when needed. The focus group interviews lasted 52 and 40 
minutes respectively, and the individual interview for 25 minutes. The interviews 
were audio recorded and transcribed verbatim by the author of the thesis. The 
transcripts were checked against the audio recording.
5.4.3 Data analysis
Data were analyzed using inductive qualitative content analysis (Elo & Kyngäs, 
2008). Initially, the interview transcripts were read through several times to 
make sense of the data and get a sense of the whole. Text related to symptoms or 
self-care was coded using open coding where notes and headings were written 
in the text while reading it. Two authors coded the text and the codes were then 
transferred to a coding sheet in Microsoft Excel 2010 where similar codes were 
grouped together to create categories. The codes and categories were discussed by 
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the researchers and revised until agreement was reached. Trustworthiness (Lincoln 
& Guba, 1985) for the analysis was ensured by involving several researchers with 
different experiences within the field and by having verbatim transcripts to check 
when needed. Further, quotes were presented to confirm the findings.
5.5 Phase II – Assessing feasibility of Interaktor 
 pancreas version (Study II)
5.5.1 Sample
During a period of 4 months in 2013-2014, all patients (n=33) who were  scheduled 
to undergo PD at Karolinska University Hospital due to a suspected tumor in the 
pancreatic or periampullary region were screened for eligibility. Exclusion cri-
teria were follow-up care out-side of Stockholm county (n=12), unable to read 
and understand Swedish (n=1) and logistic reasons (n=3). Logistic reasons were 
if a patient was estimated to be discharged when the outpatient unit was closed 
over Christmas or if three other patients already were reporting at the same time 
since only one nurse was responsible for monitoring reports. After the screening 
process, 17 patients were eligible before surgery. All, except one who could not 
be reached, were asked to use the app for 4 weeks starting the first day at home 
after discharge following surgery. Four patients declined, five patients could not 
be included after surgery for different reasons, and one started to use the app but 
dropped out after being readmitted to the hospital after 3 days at home. Thus, six 
patients were included in the study. The included patients ranged in age from 57 to 
74 years (mean 65 years), and there were three men and three women. Three patients 
were diagnosed with ductal adenocarcinoma and three of periampullary cancer.
One nurse at the surgical outpatient unit was asked to respond to alerts from all 
participating patients.
5.5.2 Procedure
At the time of Study II, the Interaktor app was not yet downloadable to every 
smartphone or tablet. Therefore, the patients were supplied with a smartphone with 
the app installed. The researcher instructed the patient about the different compo-
nents and thereafter the patient practiced sending a report under the researcher’s 
supervision. The report was then shown in the graphs and discussed together. The 
self-care advice, including hyperlinks to websites, was introduced. Furthermore, a 
written manual for using the app was given to the patients to take home. The manual 
contained illustrations and instructions and was created by Health Navigator and 
checked by the author of the thesis. The patients were instructed to report symp-
toms daily for 4 weeks starting the first day after discharge from the surgical or 
rehabilitation clinic. If the patients received chemotherapy during these weeks, they 
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were instructed to continue to use the app in the same way. A reminder to report 
was sent through the app every day. The patients were thoroughly informed both 
orally and in writing that in case of an alert they would only be contacted during 
working hours (8 a.m. to 4 p.m. on weekdays) because the report could only be 
monitored by a nurse during this time. In case an alert had been triggered during 
weekends, an interaction was initiated on Monday morning. The allocated nurse 
was employed at the surgical clinic but was not primarily involved in the patients 
care. The nurse was instructed to call the patients if she received an alert-SMS 
and to document the actions taken in the web-interface. The patients were also 
asked to write down comments and thoughts about the app if they appeared on 
a predesigned note sheet, which was to be collected at the end of the reporting 
period. The patients got a telephone number and e-mail address to a researcher in 
case of technical difficulties and the same researcher weekly monitored the patient 
reports and that alerts were submitted and responded to as intended.
5.5.3 Data collection
Data was collected from three sources 1) logged data, 2) individual interviews with 
the patients and 3) an interview with the nurse assigned to the study. None of the 
patients had used the predesigned note sheet to write down comments.
1) Logged data concerning the number of reports, the number of reported symp-
toms, alerts, and documented interactions were extracted as an encrypted 
Microsoft Excel 2010 file from the database hosted on the secure server. Data 
regarding the use of the self-care advice could not be logged in this version.
2) The patients were interviewed about their experiences of using the app after 
their final report. Interviews were chosen to get an understanding of the 
patients experiences (Patton, 2015). A semi-structured interview guide was 
used to cover relevant areas. The same initial question was used for all inter-
views but the following questions could come in different order depending 
on the patients responses (Kvale & Brinkmann, 2009). The initial question 
was: “What was it like to use the app?” Then followed questions regarding 
experiences of the content of included questions and self-care advice, view-
ing graphs of previous reports, being contacted after an alert (if applicable), 
technical issues, and how long it would be relevant to report symptoms. The 
interview ended with the question “What has the app meant for you during 
this time?” Depending on the extent of the patients’ answers, probing questions 
like “can you elaborate or give an example” were used (Patton, 2015). The 
interviews lasted for a median time of 34 min (range 22 to 54 min) and were 
audio recorded. All patients were interviewed in their homes. 
3) The nurse was interviewed over the phone about her experiences in receiving 
and managing the alerts and using the web-interface. Notes were taken during 
the interview.
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5.5.4 Data analysis
1) The extracted logged data were analyzed using descriptive statistics.
2) The patients’ interviews were transcribed verbatim and were analyzed using 
qualitative content analysis as described by Elo and Kyngäs (2008). The 
texts from all the patients’ interviews were put together to create one unit 
of analysis. The text was read through to get a sense of the whole. After that, 
an open coding was performed by noting codes in the margins of the text. 
The codes were then transferred to a coding sheet where similar codes were 
put together to create categories. Trustworthiness was insured in several 
ways (Elo & Kyngäs, 2008; Graneheim, Lindgren, & Lundman, 2017). All 
the researchers had different experiences in cancer care and research and 
thereby preunderstandings could be identified and discussed. Data from all 
participants were analyzed and characteristics of patients are described as 
detailed as possible without compromising integrity. Categories were created 
after discussions among all of the authors and returning to the text when 
divergences arose. 
3) The notes from the interview with the nurse were coded and analyzed 
without creating categories.
5.6 Phase III – Evaluation of Interaktor pancreas version 
(Study III and IV)
5.6.1 Sample
Inclusion criteria for Study III were patients scheduled to undergo PD due to a 
suspected malignancy whose follow-up care was planned to Karolinska University 
Hospital and who were able to read Swedish. The patients were invited conse-
cutively before surgery to participate in the study. Inclusion and data collection 
of the control group were made before the intervention group. During a period 
of 14 months, in 2012-2013, 60 patients were found to be eligible for the control 
group of which 42% were women. During a period of 16 months, in 2015-2016, 
115 patients were found to be eligible for the intervention group of which 50% 
were women. Six patients declined to participate in the control group, their median 
age was 71 years (range 56-81 years) and three (50%) were women. A total of 35 
patients, declined to participate in the intervention group, their median age was 
72 years (range 58-85 years) and 21 (60%) were women. Only patients whose 
microscopic examination showed a malignant tumor were included in the analysis. 
Patients who dropped out of the study before the first follow-up six weeks after 
surgery were not included in the analysis. Reasons for dropping out were not always 
stated but some patients explained that they felt well and had no symptoms to report 
and others that they lacked the energy to continue. Further exclusion criterions 
21
after surgery are shown in Fig. 4. A final sample of 33 patients in the control group 
and a final sample of 26 patients in the intervention group were included in the 
analysis. The control group received standard care, as described under “Setting 
and standard care” on page 13, and the intervention group received standard care 
and the intervention. The sample in Study IV consists of the patients from Study 
III who were included in the intervention group (n=26).
Figure 4. Flowchart over the inclusion process in Phase III. IPMN = intraductal papillary 
mucinous neoplasm, NET = neuroendocrine tumors.
Eligible (n=115) 
Introduced to app (n=44) 
Included in analysis (n=26) 
Eligible (n=60) 
Excluded after PD (n=11) 
• Did not undergo PD (n=11)
Consented (n=54) 
• Data before surgery (n=25)
• Outcomes at 6 weeks (n=25)
• Outcomes at 6 months (n=25)
• Logged data from the app (n=26)
• Interviews at end of app use (n=25) 
Included in analysis (n=33) 
Intervention group 
• Data before surgery (n=33)
• Outcomes at 6 weeks (n=32)
• Outcomes at 6 months (n=30)
Control group 
Declined (n=22) 
Consented (n=93) 
Excluded after PD (n=49) 
Lost to follow-up (n=18) 
• Did not undergo PD (n=33)
• Declined to participate (n=13)
• To ill (n=3)
Declined (n=6) 
• Deceased or too ill at discharge (n=5)
• Drop-out (n=8)
• None malignant IPMN/NET or
pancreatitis (n=5)
Continued in study (n=43) 
Lost to follow-up (n=10) 
• Deceased or too ill at discharge (n=3)
• None malignant IPMN/NET or
pancreatitis (n=7)
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5.6.2 Procedure for the intervention group
Within a few days of discharge, the researcher met the patients (n=44) in the inter-
vention group individually to inform the patients on how to use Interaktor. At the 
time of this study the Interaktor app could be downloaded to any smartphone or 
tablet and therefore patients with own access to a smartphone or tablet got help 
to download the app on that device. Patients who did not have access to a device 
could borrow a smartphone to use during the study period. The patients got an 
individual user name and pin code to use when logging in to the app and practiced 
submitting a report under the researcher’s supervision. Further, the graphs over 
previous reports and the self-care advice components were showed. An updated 
manual with illustrations and instructions of how to use the app were given to the 
patients to take home. At six occasions the researcher could not meet the patients 
before discharge; instead the patients were visited in their homes or got instructions 
over the phone. The patients were instructed to submit a report once a day starting 
on the first day at home after discharge and until six months after surgery. The 
patients were thoroughly informed that reports were only monitored during work-
ing hours (8 a.m. to 4 p.m. on weekdays) and that in case of an alert they would 
only be contacted during these hours. In case an alert had been triggered during 
weekends, an interaction was initiated on Monday morning. If in need of contact 
outside of working hours they were instructed to contact healthcare according to 
standard care procedure described on page 13. Also, the patients got contact infor-
mation to the researcher in case of technical problems with the app. The researcher 
monitored the patients’ reports during the first days to identify if there were any 
problems. If no reports had been submitted the researcher called the patients to 
give further instructions. One patient, who borrowed a smartphone, required two 
additional training sessions over the first weeks of reporting and the researcher 
then visited the patient at home. Patients undergoing adjuvant chemotherapy were 
asked to continue to use the app until one week after their final chemotherapy 
cycle which could be up to 9 months after surgery depending on the start of the 
first cycle and any pauses in cycles.
5.6.3 Data collection
5.6.3.1 Descriptive data and questionnaires (Study III)
Four sets of data were collected; 1) descriptive data, 2) Sense of coherence (inde-
pendent variable), 3) Health-related quality of life (outcome variable) and 4) Self-
care activity (outcome variable).
1) A number of descriptive data were collected. Data concerning age, sex, 
histopathology of tumour, and oncological therapy were collected from the 
patients’ medical records. Data concerning living situation and educational 
level were collected via questionnaires to patients before surgery, or if patients’ 
responses were missing at that time data were collected after surgery.
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2) Sense of coherence (SOC) were collected before surgery, six weeks after 
surgery and 6 months after surgery using the scale developed by Antonovsky 
(1987) which reflect a person’s inner resource for coping with stressful life 
events and is built on how comprehensive, manageable, and  meaningful life 
appears. The SOC scale has been used in a wide range of samples including 
people of different countries, ages and health status and found to have high 
validity and reliability (Eriksson & Lindström, 2005). The scale is a self-
assessment questionnaire that consists of 13 items that measure SOC (SOC-13). 
The questionnaire utilizes a 7-point scale with two anchoring responses. The 
total score range from 13-91 points where a higher score indicates a higher 
degree of SOC. Levels of SOC were collected to be used as an independent 
variable since level of SOC are normally stable over time (Eriksson & 
Lindström, 2005; Lindblad, Sandelin, Petersson, Rohani, & Langius-Eklof, 
2016) and since a high SOC has shown predictive validity for a good HRQoL 
(Pillay et al., 2015; Rohani, Abedi, Omranipour, & Langius-Eklöf, 2015) and 
higher self-care activity level (Fex, Flensner, Ek, & Söderhamn, 2012). 
Further, SOC has shown predictive value for survival, argued to depend on 
that patients with high SOC can understand the need, handle side-effects and 
have enough motivation to go through difficult cancer treatments (Lindblad 
et al., 2018). Internal consistency of SOC-13 in Study III showed Cronbach’s 
alpha ≥ 0.87.
3) Data on health-related quality of life were collected before surgery, six weeks 
after surgery, and six months after surgery as an outcome variable using the 
Swedish versions of EORTC QLQ-C30 (version 3) and the pancreas module 
QLQ-PAN26. The EORTC QLQ-C30 has shown high validity and reliablity 
for assessing the HRQoL of patients with cancer (Aaronson et al., 1993; 
Björdal et al., 2000) and has been widely used. It is a self-assessment question-
narie consisting of 28 questions with a 4-point rating scale; not at all, a little, 
quite a bit, very much and two questions with a 7-point scale from very poor 
to excellent. The questions are scaled in one global health status domain, 
five functional domains exploring physical, role, emotional, cognitive and 
social functioning, as well as eight symptom scales/items namely fatigue, 
nausea/vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea 
and one item concerning financial difficulties. All of the scales and single-
item measures range in score from 0 to 100 where a high score for the global 
and functional scale represents a high level of HRQoL/functioning, whereas 
a high score for symptom scales/items represent high levels of symptoms 
or problems (Aaronson et al., 1993). The disease-specific pancreatic cancer 
module QLQ-PAN26 is not yet fully validated but is one of the most used 
instruments for patients with pancreatic cancer and is currently undergoing 
phase III testing. It comprises 26 questions, with the same 4-point rating 
scale, and is divided in seven multi-item scales assessing pancreatic pain, 
digestive symptoms, altered bowel habit, hepatic symptoms, body image, 
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satisfaction with healthcare, and sexuality, as well as 10 single items assessing 
bloating, taste/smell alterations, indigestion, flatulence, worry about low 
weight, muscle weakness, xerostomia, side-effects, worry about future health, 
and planning social activities. Higher scores in symptoms and satisfaction 
scales/items represent high level of symptoms or satisfaction, whereas a high 
score for sexuality represents worse sexual function (Fitzsimmons et al., 
1999). To ensure reliability internal consistency was measured for all sub-
scales by Cronbach’s reliability coefficient α. All showed an acceptable 
Cronbach’s alpha of > 0.70 (Pallant, 2016) except for cognitive function 
at six months (α=0.62), nausea/vomiting before surgery (α=0.62) and at six 
months (α=0.32), pancreatic pain at six months (α=0.62), digestive symptoms 
at six weeks (α=0.63), altered bowel habits at all time points (α=0.62-0.65) 
and hepatic symptoms at six weeks (α=0.06) and at six months (α=0.60). 
Cronbach’s alpha are dependent on the number of items within the scale 
and it is not uncommon that scales with few items can have small alphas 
(Pallant, 2016). Therefore, the mean inter-item correlation was measured 
for scales with two items and a Cronbach’s alpha that did not reach > 0.70. 
Then, only the subscale hepatic symptoms six weeks after PD showed 
correlation outside the reference range of 0.15-0.50, namely 0.03.
4) Data on self-care activity levels were collected before surgery, six weeks 
after surgery, and six months after surgery as an outcome variable using the 
Swedish version of the Appraisal of Self-Care Agency scale (ASA-A). The 
ASA-A scale is a self-assessment questionnaire that measures the activation 
of power and engagement in self-care activities, based on Orem´s self-care 
deficit theory of nursing (Söderhamn, Evers, & Hamrin, 1996a). The ASA-A 
have been validated in Swedish in a sample of older lucid people and showed 
high reliability and validity (Söderhamn, Lindencrona, & Ek, 1996b). It is a 
Likert-type scale including 24 items for self-appraisal, each item having five 
response categories ranging from 1 (‘totally disagree’) to 5 (‘totally agree’). 
The total score range from 24-120 points, where higher scores reflect a higher 
degree of self-care activity. Internal consistency of ASA-A in Study III 
showed Cronbach’s alpha ≥ 0.86.
5.6.3.2 Logged data from the app (Study III and IV)
Data concerning number of submitted reports, reported symptoms, triggered alerts, 
free text comments and viewed self-care advice by the intervention group were 
extracted in an encrypted Microsoft Excel 2010 file.
5.6.3.3 Interviews (Study IV)
The patients in the intervention group were interviewed, after their final report, 
about their experiences of using the app. A semi-structured interview guide was 
used to cover relevant areas (Kvale & Brinkmann, 2009) and to ensure trust-
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worthiness (Lincoln & Guba, 1985). Questions were “What was it like to use 
the app?”, “In which way have you been in contact with healthcare?” and “In 
which way have you been able to be involved in your care?” Probing questions 
were used to deepen the patients’ responses (Patton, 2015). All interviews were 
conducted by the author of the thesis. The interviews lasted for a median time of 
31 min (range 16 to 71 min) and were audio recorded. To ensure that the patients 
were comfortable they were interviewed either in their own home (n=21) or at the 
hospital (n=4) according to their own choosing.
5.6.4 Data analysis
5.6.4.1 Questionnaires (Study III)
One patient in the intervention group had incomplete data before surgery but 
completed all the other measurements and was therefore included in the analysis. 
The items in the SOC-13 where processed according to the manual (Antonovsky, 
1987) where five items are reversed, and the scores were then aggregated to a total 
SOC-score. Randomly distributed missing values (0.2% in total) were imputed 
according to the manual. Missing questionnaires were excluded (7.8% in total).
The items in EORTC QLQ-C30 were processed according to the EORTC scoring 
manual (Fayers et al., 2001) and the items in EORTC QLQ-PAN26 according to 
CD Johnson, responsible for the pancreas module (personal communication). Raw 
scores where linearly transformed into 0-100 scales. Randomly distributed missing 
values in multi-item scales (0.4% in total) were imputed according to the scoring 
manual while missing values for single-items (0.7% in total) were not imputed. 
Missing questionnaires (4% in total) were not imputed.
The items in the ASA-A scale were processed according to Fex and colleagues 
(2012). Nine items, negatively stated, were reversed in the summation of the scores. 
Randomly distributed missing values (0.2% in total) were given a neutral score of 
3 (‘neither disagree nor agree’). If the patients had more than three missing values 
the whole questionnaire was excluded (Fex et al., 2012). These excluded question-
naires together with non-returned questionnaires represented 9.6%. 
Effect size was calculated by subtracting the group means and dividing the result 
with the pooled standard deviation giving Cohen’s d. Cohen’s d was interpreted 
as small if d = 0.2, medium if d = 0.5 and large if d = 0.8 (Cohen, 1988). Further 
analyses were performed using IBM SPSS Statistics 24 where a 2-tailed statis-
tical significance level of p < 0.05 was applied. Between-group analyses were 
performed using chi-square or Fisher’s exact test for categorical variables and 
independent sample t-test for continuous variables. Variables showing signifi-
cant mean differences at six weeks and six months were run in multiple linear 
regression models as dependent variables with group affiliation (coded as control 
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group=0, intervention group=1), chemotherapy (coded as No=0, Yes=1) and SOC 
scores collected 6 weeks after surgery as independent variables using the standard 
method. Chemotherapy was used as an independent variable since decisions on 
chemotherapy may be based on patients’ general condition at that time. To evaluate 
changes over time an ANOVA for repeated measures was analyzed separately for 
the intervention group and the control group.
5.6.4.2 Logged data from the app (Study III and IV)
Logged data from the app were analyzed with descriptive statistics using Microsoft 
Excel 2010. Adherence to report was calculated as the number of days a patient 
submitted a report divided by the number of days a patient was intended to report, 
and presented as a mean percentage in the whole group. Data was analyzed as one 
data set throughout the whole reporting period (Study IV) but also separated as 
two data sets, one with data from the first four weeks and one with data for the rest 
of the reporting period (Study III). This time point approximately corresponds to 
the measurements at six weeks after surgery and also to when patients normally 
begin chemotherapy.
5.6.4.3 Interviews (Study IV)
The patients’ interviews were analyzed using thematic analysis as described by 
Braun and Clark (2006). First, all interviews were transcribed verbatim and read 
through several times. Statements regarding the app were systematically coded 
throughout the entire dataset with an inductive approach. A code could consist of 
a few words or a whole sentence. Similar codes were then put together and created 
themes. All data in one theme were then reviewed to see if the theme worked in 
relation to the codes. This reviewing process was made by all authors. If a theme 
did not work the process to collate codes started from the beginning until all themes 
corresponded in relation to the codes and the entire dataset. During the whole 
 process themes were defined, named and re-named. Final analysis and adjust-
ments were made during the manuscript-writing. Trustworthiness was ensured 
by following Braun and Clarks (2006) 15-points checklist.
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6 ETICHAL CONSIDERATIONS
All work comprised in this thesis was made according to the ethical principles 
stated by the Declaration of Helsinki (World Medical Association, 2013) and the 
regulations by the Swedish Act concerning Ethical Review of research Involving 
Humans (The Swedish Riksdag, 2003). The principles involve informed consent 
of participants, that information must be easy to understand, and that participants 
can choose not to continue to participate at any time. Further, the consequences of 
the research should be good for society, the research should mean minimal risks 
and the participants’ integrity and interest must come before the research. The 
law also stipulates how sensitive information regarding participants should be 
handled. The studies in the thesis have undergone ethical examination and were 
approved by the Regional Ethical Review Board in Stockholm, Sweden (Reg.no: 
2011/1780-13/2). When implementing mHealth several ethical considerations exist 
(Botrugno, 2019). mHealth enables healthcare professionals to have access to a 
great portion of patients’ daily lives and consequently a large portion of sensitive 
data. These sensitive data need to be protected against unauthorized access and 
healthcare professionals are obliged to monitor all of the data regardless of its rel-
evance to the patient’s conditions. This could lead to the exposure of unforeseen 
liability issues for healthcare professionals. Also, to ensure effectiveness of the 
mHealth intervention substantial engagement is required by patients, who need to 
contribute to the management of their own diseases through an active approach. 
While this could be positive in the sense that it improves patients’ awareness of 
their own health conditions, the balance between patient’s autonomy and the 
healthcare professionals responsibilities can be problematic (Botrugno, 2019).
The patients in Study I-IV received written information about the study in con-
nection to a clinical visit prior to surgery. After 1-2 weeks a researcher called the 
patient to answer questions about the study and ask if the patient wanted to par-
ticipate. Patients who accepted to participate signed a written consent but were 
informed that they could withdraw from the study at any time without specifying 
a reason. When the app was introduced to the patients upon discharge information 
about the study was given once again. In Study III-IV a researcher called patients 
using the app after approximately one month to ask if they wanted to continue 
to use the app. All patients in Study 1-IV were given a specific code which was 
stored separately from clinical and sociodemographic data and answers to question-
naires. Personal data on participating healthcare professionals in Study II were 
not collected. In the connected web interface patients name and personal number 
are logged to ensure easy access for the participating nurses to the patients’ medi-
cal records. All logged data from the app and the web interface were logged on a 
secure server hosted by the participating company Health Navigator. The server 
was approved by The Swedish Data Protection Authority. Log-in number and 
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password to the web interface was given to nurses responsible to monitor patients, 
to researchers involved in the project and to appointed staff at Health Navigator 
for technical support. The app required a user name and password unique for each 
patient. A researcher monitored the web interface weekly to ensure that alerts 
were being responded to. Completing a daily electronic symptom questionnaire 
may cause patients to focus more on their symptom experiences than if they were 
not asked to complete these symptom questionnaires. However, the patients were 
encouraged to raise this with their contact nurse who followed them throughout 
the study. Also, the patients were given the phone number and e-mail address to a 
researcher in case they experienced difficulties with the app or felt unsure about 
usage. Being interviewed about personal experiences can bring forth unpleasant 
emotions. Therefore, all interviews were conducted by a nurse with years of expe-
rience of cancer and critical care.
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7 RESULTS
7.1 Phase I – Development of Interaktor pancreas 
 version (Study I)
7.1.1 Foundation for the content
7.1.1.1 Symptoms to assess
In Study I, five areas of symptoms were identified through the data analysis of 
interviews with patients and healthcare professionals, namely eating, fatigue, bowel 
function, emotional wellbeing and pain. Eating difficulties included descriptions 
of appetite loss, taste- and smell alterations, rapid satiety and nausea, sometimes 
with vomiting. Several of the symptoms, especially fatigue and loose stool, were 
described to lead to reduced ability to engage in social activities. Pain in the surgi-
cal area was described to be mostly present in the first weeks after discharge and 
dependent on activity level, amount of oral intake, flatulence or that the opioids 
had been reduced too quickly. There was a consistency in descriptions of symp-
toms between the patients and the healthcare professionals except for emotional 
wellbeing. The healthcare professional experienced that patients struggled with 
anxiety and sadness after surgery and a few of the interviewed patients mentioned 
it. Examples of quotes from the patients and the abstraction to symptoms to assess 
in Interaktor pancreas version are shown in Table 3.
Table 3. Examples of quotes from patients following pancreaticoduodenectomy 
and the abstraction to symptoms to assess in Interaktor pancreas version.
Quote Symptom to assess
“Sometimes I want food but my stomach is crammed full.” Eating difficulties
“I can’t manage to watch TV. I can’t manage to read /…/. 
I can barely manage to remove the plate from the table.”
Fatigue
“I need to go to the toilet as soon as I have eaten something and 
it just runs straight through me.”
Loose stool
“I became a completely different person when I came home, 
and that’s also difficult to accept, and then this depression comes. 
I fall apart and it’s tough, it’s really tough.”
Depression
“At first I couldn’t do anything because I had such pain. Not able 
to lift anything and such.”
Pain
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7.1.1.2 Self-care advice to include
Self-care advice and strategies to manage the experienced symptoms were described 
by both the patients and the healthcare professionals but to a varying degree. Most 
patients had at discharge lacked advice on how to manage symptoms, especially 
regarding the dosage and function of enzyme supplement to reduce loose stool and 
weight loss and how to manage pain and reduce pain medications. On the other 
hand, the healthcare professionals expressed that patients repeatedly get advice 
but also pointed out that the patients often forget or cannot absorb all the advice 
they were given while at the hospital. In the interviews several self-care advice and 
strategies were brought up like forcing oneself to eat at predetermined time points, 
eat smaller amounts of food but more often, letting someone else cook the meals, 
distraction by doing something fun and stimulating and exercise. Examples of 
quotes from the interviews with the patients and the abstraction to important areas 
of self-care advice to include in Interaktor pancreas version are shown in Table 4.
Table 4. Examples of quotes from the interviews with patients following 
 pancreaticoduodenectomy and the abstraction to important areas of self-care 
advice to include in Interaktor pancreas version.
Quote Self-care advice to include
“Mostly my wife has been cooking. It wouldn’t have 
worked out for me if I’d had to cook the meals, feel nau-
seous and then eat the food.”
Advice on eating
“I still haven’t quite learnt about Creon a hundred percent. 
Sometimes I forget to take them (…). If you could only get 
some help on how much to eat. Someone said you could 
eat as much as you liked and someone said one pill was 
enough. There have been conflicting messages about it.”
Advice on pancreatic enzyme 
supplements
“I didn’t get any information about the pain medication 
before I went home. I stopped taking them when I got 
home because I thought I had recovered. But I had a lot 
of pain. I had been too optimistic. So I called and they 
said I had to continue taking them.”
Advice on pain management
“I have been careful to be as mobile as possible and tried 
from the beginning to go out for short walks /…/. If I lay 
down I only get more and more tired.”
Advice on fatigue
7.1.2 Development
7.1.2.1 Symptom assessment
The pancreas version of Interaktor was determined to contain twelve common 
symptoms and concerns important to assess in the target population based on the 
results in Study I. The included symptoms and concerns were: fever, eating dif-
ficulties, nausea, vomiting, loose stool, constipation, pain, dizziness, fatigue, sad-
ness and worry, and problems with daily activities at home and outside the home.
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7.1.2.2 The risk assessment model
The risk assessment model for alerts was created by the research group consist-
ing of healthcare professionals with expertise in cancer and pancreatic surgery. 
The alerts were triggered in different ways depending on how the symptom was 
reported; either on level of occurrence, frequency or distress. Some alerts were 
triggered after one report and some after multiple consecutive reports (Table 5).
Table 5. The risk assessment model for alerts in the version of Interaktor 
adapted for patients who have undergone pancreaticoduodenectomy.
Symptom Lowest rated as Alert Trigged after… Type of Alert
Fever/Chills Occurrence “Yes” One report Red
Pain in abdomen  
and/or back
Frequency “Almost always” One report Red
Vomiting Frequency “Almost always” One report Red
Dizziness Frequency Almost always One report Red
Vomiting Frequency “Sometimes” 2 consecutive days Yellow
Dizziness Frequency “Sometimes” 2 consecutive days Yellow
Pain in abdomen  
and/or back
Frequency “Often” 2 consecutive days Yellow
Loose stool Frequency “Often” 3 consecutive days Yellow
Constipation Occurrence “Yes” 3 consecutive days Yellow
Eating difficulties Frequency “Often” 7 consecutive days Yellow
Nausea Frequency “Often” 7 consecutive days Yellow
Fatigue Distress “Rather much” 7 consecutive days Yellow
Sadness/
depression/worry
Distress “Rather much” 7 consecutive days Yellow
Problems  
performing daily 
activities at home
Distress “Rather much” 7 consecutive days Yellow
Problems  
performing daily 
activities outside 
home
Distress “Rather much” 7 consecutive days Yellow
7.1.2.3 Self-care advice
Twenty-two areas of different self-care advice were included in the pancreas 
version. These were identified in Study I and through additional searches in the 
literature and guidelines. The advice was based on the latest evidence and refers 
to the reported symptoms, for example, advice on nutrition and physical activity, 
but also to other areas of importance such as advice on how to manage the surgi-
cal wound and recommendations on alcohol consumption.
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7.2 Phase II – Assessing Feasibility of Interaktor 
pancreas version (Study II)
7.2.1 Logged data
Among the patients (n=6) who consented to test Interaktor pancreas version for 
four weeks, adherence to report symptoms daily was on average 84% (median 84%, 
range 68-93%). In total, the patients submitted 141 reports which included 652 
symptoms, namely in mean 5 symptoms per day. In total, all symptoms included 
in the app were reported. Fatigue was reported by all patients and was the most 
commonly occurring symptom whereas dizziness was reported by two patients 
and the least occurring symptom (Fig. 5). 
Figure 5. Number of symptoms reported by patients during the first four weeks after 
discharge following pancreaticoduodenectomy.
Of the 141 reports, 58 (41%) generated alerts and the total number of alerts was 
134 and the range per patient was 0-78. The distribution between red and yellow 
alerts was 54% red and 46% yellow. The most common alert was related to pain 
in the abdomen and/or back (Fig. 6). Two of the patients generated alerts almost 
daily, mostly connected to the question about pain in the abdomen and/or back.
Of the 58 reports generating alerts, 35 (60%) resulted in no interaction with the 
nurse. The non-interactions were due to the fact that patients had chosen not to 
send an SMS (n = 30), because an SMS was not sent by mistake (n = 2), due to 
a system error (n = 1), or because the SMS was missed by the nurse (n = 2). The 
choice not to send an SMS was made by the two patients who triggered most of 
the alerts and were mostly in connection to alerts regarding pain. Interactions with 
patients were documented by the nurse in the web-interface and consisted of advice 
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and discussions about different symptoms or a re-direction to another healthcare 
professional. An example of the change of a patients reporting of a symptom’s 
frequency after an interaction with a nurse following an alert is shown in Fig. 7. 
Figure 6. Percentile distribution the number of alerts (n=134) triggered by patients 
during the first four weeks after discharge following pancreaticoduodenectomy.
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Figure 7. Example of a patients report on the frequency of symptom loose stool. 0 = not 
occurring, 1 = occurs almost never, 2 = occurs sometimes, 3 = occurs often, 4 = occurs 
almost always. An alert was triggered after occurring often or almost always for three 
 consecutive days. After being advised to increase the pancreatic enzyme supplements the 
symptom does not occur during the following days.
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7.2.2 Experiences from patients
The patients perceived the symptom questions as relevant and that they comprised 
all experienced symptoms. The structure of the questions regarding frequency 
and distress were mostly found to be sufficient but sometimes to include too few 
nuances. The app was described to be easy to use and navigate through. Some 
misunderstandings arose regarding the patient’s choice not to be contacted by a 
nurse following an alert. For instance, one patient was unaware that he had chosen 
not to be contacted and therefore expected a call that did not happen. There were 
discrepancies in opinion about this component where some patients felt that there 
was not always need for contact while other patients felt that it was hard to decide 
by themselves when contact was needed. The patients felt reassured and cared 
for at home and thought that the app enable an easy way to come in contact with 
healthcare. Further, they had gotten support for symptom management either by 
reading the self-care advice or by getting support from the nurse or other health-
care professionals following an alert.
7.2.3 Experience of the nurse
The nurse expressed that Interaktor was valuable for the patients but found it dif-
ficult to support patients during the time they underwent chemotherapy because 
a nurse working at a surgical clinic is not normally an expert on the symptoms of 
oncological treatment. Also, the nurse felt insecure whether or not to call a patient 
if no SMS was received but the alert was visible in the web-interface.
7.2.4 Changes made before start of Phase III
Based on the results that several of the alerts did not lead to an interaction with the 
nurse and that patients continued to report the alerting symptoms the component 
where patients could choose whether or not to send an alert was removed. Instead 
a free text section for patients to write messages was added. Further, the consecu-
tive alert on pain was modified to be triggered after seven days instead of two and 
some of the questions were rephrased according to the patients’ suggestions. Three 
additional questions were added for patients undergoing adjuvant chemotherapy 
and some advice was added and some was modified as to relate to chemotherapy. 
During chemotherapy all alerts were programmed to be triggered after one report, 
and none after several consecutive days, since patients have weekly contact with 
healthcare professionals during that time (see manuscript for Study IV for details).
35
7.3 Phase III – Evaluation of Interaktor pancreas 
 version (Study III and IV)
7.3.1 Descriptive data including sense of coherence
The analysis of descriptive data and sense of coherence showed no statistically sig-
nificant differences between the intervention group and the control group (Table 6).
Table 6. Descriptive data and sense of coherence of study participants (n=59) 
in Phase III.
Descriptive data IG (n=26) CG (n=33) p
Age, years
Mean (SD) 67 (8,7) 66 (8,8) 0.78†
Median (range) 67 (51-82) 66 (47-82)
Sex, No. (%)
Female 9 (35) 13 (39) 0.79‡
Male 17 (65) 20 (61)
Living situation, No. (%)
Married/living with partner 21 (81) 25 (76) 0.76‡
Living alone 5 (19) 8 (24)
Highest education level, No. (%)
Junior compulsory 1 (4) 5 (15) 0.18§
Senior high school 9 (35) 15 (45)
Postgraduate or university 15 (58) 12 (36)
Missing data 1 (4) 1 (3)
Histopathology, No. (%)
Pancreatic ductal adenocarcinoma 12 (46) 18 (55) 0.55§
Periampullary cancer 12 (46) 12 (36)
Invasive IPMN-cancer 2 (8) 1 (3)
Invasive neuroendocrine carcinoma 0 (0) 2 (6)
Chemotherapy, No. (%)
Yes 22 (85) 22 (67) 0.14§
No 4 (15) 11 (33)
Sense of coherence, mean (SD)
Before surgery 74.7 (8.5) 72.3 (12.5) 0.45†
6 weeks after surgery 73.3 (12.5) 73.3 (11.8) >0.99†
6 months after surgery 75.3 (12.4) 73.2 (12.3) 0.54†
IG = Intervention group, CG = Control group, IPMN = intraductal papillary mucinous neoplasm 
† 2-tailed t-test 
‡ Chi-square 
§ Fisher’s exact test
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7.3.2 Impact on health-related quality of life and self-care activity 
(Study III)
Before surgery, the intervention group rated significantly less worry about low 
weight with moderate effect size (p=0.039, d=0.6). At six weeks after surgery the 
intervention group overall rated higher levels of functioning and satisfaction and 
fewer symptoms than the control group when comparing mean values (Fig. 8). 
Figure 8. Mean values of EORTC QLQ-C30 and EORTC QLQ-PAN26 as reported by 
patients six weeks following pancreaticoduodenectomy. For outcomes left of the  dotted 
line higher values represent better quality of life/functioning or more satisfaction. For 
outcomes right of the dotted line higher values represent more symptoms or worse 
functioning.
Cognitive functioning (CF), Emotional functioning (EF), Physical functioning (PF), 
Satisfaction  with healthcare (SH), Social functioning (SF), Global health status (QL), 
Role functioning (RF), Sexuality (SX), Fatigue (FA), Taste/smell alterations (TA), Worry 
about future health (FU),  Digestive symptoms (DS), Planning social  activities (PL), 
Appetite loss (AP), Muscle weakness (WK), Xerostomia (XE), Side-effects (SE), 
Worry about low weight (WL), Insomnia (SL), Body image (BI), Flatulence (FL), 
Indigestion (ID), Bloating (BL), Pancreatic pain (PP), Pain (PA), Dyspnea (DY),  
Diarrhea (DI), Altered bowel habits (BW), Nausea/vomiting (NV), Financial  
difficulties (FI), Constipation (CO), Hepatic symptoms (HP).
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Statistically significant differences also with moderate or high effect sizes were 
shown for emotional functioning (p=0.001, d=0.9), worry about low weight 
(p=0.001, d=1.0), constipation (p=0.003, d=0.9), nausea/vomiting (p=0.004, 
d=0.9), appetite loss (p=0.005, d=0.8), pancreatic pain (p=0.007, d=0.8), flatulence 
(p=0.035, d=0.6) and pain (p=0.047, d=0.5). Moderate effect size was shown for 
physical functioning (d=0.5), fatigue (d=0.5), digestive symptoms (d=0.5), hepatic 
symptoms (d=0.5), body image (d=0.5), muscles weakness (d=0.5) and planning 
social activates (d=0.5).
At six months after surgery the intervention group rated significantly fewer hepatic 
symptoms (p=0.035), less worry about low weight (p=0.037) and a higher self-care 
activity rate (p=0.033) all with a moderate effect size (d=0.6).
Over time, the intervention group reported non-significant changes in 21 of the 
EORTC scales as compared to 8 for the control group. Examples of within-group 
changes over time are presented in Fig. 9. There were no statistically significant 
changes in ASA-A in any of the groups over time.
Figure 9. Within-group changes over time for symptoms in EORTC QLQ-C30 showing 
significant differences between groups at 6 weeks after surgery. Higher value reflects 
more symptoms and range 0-100. IG = Intervention group. CG = Control group.
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In the multiple regression models, controlling for received chemotherapy and level 
of SOC six week after surgery, the intervention group still rated significantly higher 
level of emotional functioning (p=<0.001) and less constipation (p=0.001), worry 
about low weight (p=0.003), nausea/vomiting (p=0.008), appetite loss (p=0.009), 
pancreatic pain (p=0.009), pain (p=0.024) and flatulence (p=0.040) six weeks 
after PD and fewer hepatic symptoms (p=0.029) and higher self-care activity level 
(p=0.040) six months after surgery.
7.3.3 Logged data from the app (Study III and IV)
7.3.3.1 Adherence to report as intended
Patients who used the app adhered to report symptoms for in median 82% of the 
intended days (24-100%). Highest adherence was seen during the first four weeks 
after discharge when adherence was 95% in median (range 32-100%). Patients used 
the app for a median of 190 days (range 35-245 days). Reasons to cease report-
ing in advance were; own choice (n=1), follow-up care transferred to a clinic not 
included in the study (n=3) or death (n=1). 
7.3.3.2 Reported symptoms 
During the first four weeks the patients reported occurrence of a total of 70.5 
symptoms in median (range 8-157) and during that time fatigue, eating difficulties, 
pain and loose stool were the symptoms reported by most patients. During the 
whole study period the patients reported a total of 6320 symptoms (median 170 
per patient, range 9-994) and on group level all symptoms were reported but not 
by each patient (Table 7). The follow-up questions four-point rating values were 
all used. Levels of frequency and distress of a symptom were mostly concordant 
except for nausea, vomiting and dizziness, where patients reported a higher  distress 
level than frequency and the opposite for numbness in hands or feet (Table 7). 
Fatigue and pain were the most occurring symptoms and also reported by most 
patients (Table 7).
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7.3.3.3 Alerts
During the first four weeks alerts were triggered 3 times in median per patient (range 
0-16). The total number of alerts for the whole study period was 513 (median 9, 
range 0-87) and almost all patients (n=24) reported an alert. Of these alerts 36% 
were severe (red). The most common alert was fever which was also triggered by 
most patients (Fig. 10).
Table 7. Occurrences, frequency, and distress of the symptoms as reported in 
the app by patients (n=26) following pancreaticoduodenectomy due to cancer.
Symptoms Occurrence n=6320 Frequency Distress
(reported by number of patients) n (%) Median Range Mean Mean
Fatigue (n=24) 1445 (23) 35.5 3-198 2.4 2.3
Pain (n=23) 863 (14) 19 1-169 2.1 2.3
Problems performing activities 
outside home (n=21)
605 (9.6) 21 1-161 2.4 2.3
Nausea (n=21) 572 (9.1) 11 1-158 1.9 2.3
Eating difficulties (n=22) 535 (8.4) 13.5 2-160 2.4 2.5
Loose stool (n=24) 526 (8.3) 6 1-133 2.1 2.1
Problems performing activities 
at home (n=20)
518 (8.2) 12.5 1-127 N/A 2.3
Sadness, depression, worry 
(n=12)
386 (6.1) 14 3-169 2.3 2.3
Dizziness (n=15) 267 (4.2) 10 1-91 1.9 2.3
Numbness in hands or feet† (n=9) 204 (3.3) 2 1-85 2.2 1.8
Constipation (n=23) 132 (2.1) 4 1-28 N/A 2.2
Fever (n=16) 87 (1.4) 3 1-18 N/A N/A
Swelling/pain/redness from  
SVP/PICC† (n=9)
69 (1.1) 3 1-49 N/A N/A
Breathing difficulties† (n=7) 61 (1.0) 3 1-41 2.2 2.0
Vomiting (n=14) 50 (0.8) 2.5 1-11 1.4 2.5
 N/A = not applicable, SVP = Subcutaneous vein port, PICC = peripheral induced central catheter
† Symptoms only reported during adjuvant chemotherapy
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7.3.3.4 Free text comments
The free text comment section to communicate with healthcare was used in total 
302 times (median 7.5, range 0-90) and comments were written by most patients 
(n=24). Most comments were a description about a symptom which sometimes 
was followed by a wish for counselling or the text “You do not need to call me”. 
The patients also used the free text to document values for weight, blood glucose, 
blood pressure, and temperature or to inform on admission to hospital, going away 
on holiday, or need for prescriptions.
7.3.3.5 Self-care advice
During the first four weeks self-care advice was viewed 13.5 times in median per 
patient (range 1-93) mostly regarding pancreatic enzyme supplements, dietary 
advice and pain. During the whole study period the patients had viewed self-care 
advice in total 1231 times (median 30.5, range 3-181). The most commonly and 
least commonly viewed self-care advice during the whole period is shown in Fig. 11.
Figure 10. Distribution of the number of alerts (n=513) triggered in the app by patients 
(n=24) after discharge following pancreaticoduodenectomy due to cancer. n=number of 
patients who triggered the specific alert.
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7.3.4 Experiences of using the app (Study IV)
The overarching theme “Being seen as a person” with subthemes; “Getting your 
voice heard”, “Having an extended arm to healthcare” and “Learning about own 
health” were identified (Fig. 12).
Figure 11. The five most and least commonly viewed self-care advice and number of times 
viewed by patients using Interaktor after discharge following pancreaticoduodenectomy. 
n = number of patients viewing the specific advice.
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Figure 12. Thematic map with overarching theme, subthemes and examples of codes 
from the transcribed interview text with patients (n=25) who used Interaktor following 
pancreaticoduodenectomy.
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The patients expressed that since someone was watching how they were feeling 
they felt taken care of at home. In the dialogue with the nurse following an alert 
they could get individually adjusted advice and raise concerns important to them.
The patients described the app as a reassuring link to healthcare after discharge 
and using the app was a sort of follow-up that was otherwise lacking. Through the 
app they had a faster and easier way to get in touch with healthcare than they were 
used to. A wish that contact should always be initiated when needed was raised, 
even in nights and weekends. Some patients wanted to decide for themselves if 
a nurse should contact them following an alert since they sometimes had been 
contacted when they did not have any need of a contact. Other patients found it 
reassuring that someone else was responsible to make the decision when contact 
was needed and knowing that if someone did not call everything was satisfactory. 
Being asked about symptoms daily or watch symptoms change over time supported 
the patients to reflect and analyze how they felt. Having access to self-care advice 
provided new knowledge on symptoms and how to manage them. The patients 
expressed that having easy access to the advice was important, because informa-
tion is easy to forget or that they had not been given sufficient information before 
discharge or had not been able to absorb information at that time. Some patients 
expressed a need for individualized advice as a complement to the app.
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8 DISCUSSION
8.1 Discussion of results
The main findings in this thesis are that the Interaktor app decreased symptoms 
after PD for patients with pancreatic or periampullary cancer. Patients using the 
app had high adherence to report symptoms daily. The patients described the app 
to have relevant content and being valuable in order to have their voices heard, to 
have an extended arm to healthcare and to learn about their own health.
8.1.1 Clinical importance of the app for patients with 
pancreatic cancer
Clinically important decreases in symptoms for the patients who used the app 
were seen for a majority of the evaluated symptoms. Previous conclusions have 
been drawn that 10-points EORTC-QLQ-C30 score changes represent changes in 
supportive care needs for patients with cancer (Snyder et al., 2015). These conclu-
sions can be used when comparing the values of patients using the app to patients 
not using the app. For most values six weeks after surgery, patients using the app 
reported > 10-points higher scores in mean on the function scales and < 10-points 
lower scores in mean on the symptom scales compared to the control group. 
Further, thresholds for clinical importance of the EORTC QLQ-C30 scale have 
been determined to be; >83 for physical functioning, >70 for emotional function-
ing, <39 for fatigue and <25 for pain (Giesinger et al., 2016). Patients not using 
the app did not reach any of the thresholds six weeks after surgery while patients 
using the app did so for emotional functioning and pain. Interestingly, the patients 
using the app also reported values on emotional functioning, cognitive function-
ing, pain, dyspnea and constipation that are comparable to reports from age and 
sex matched persons from the Swedish population (Derogar, van der Schaaf, & 
Lagergren, 2012). This shows the app’s high clinical relevance and that the app 
can respond to supportive care needs for patients with pancreatic cancer. 
There was a statistically significant difference between the groups six months after 
surgery where patients using the app reported higher level of self-care activity. This 
can be a result of the long-term easy access to self-care advice and the possibility 
to discuss alerting symptoms with a nurse and also reflect patients’ descriptions of 
how they had learned about own health. Cut points for a clinical important level 
of ASA-A have previously been determined to be 95 points on the 24-120 point 
scale (Söderhamn et al., 1996b). The intervention group reached that cut point 
on all time points, while the control group did not. However, it is questionable 
how clinical important the difference is. Previously a value of > 92 have been 
described as a high level of self-care activity (Dale, Söderhamn, & Söderhamn, 
2012), indicating that both the intervention group and the control group had high 
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levels of self-care activity. Further, using conclusions for quality of life scores 
where a change in 10 % is considered clinically relevant (Osoba et al., 2005), the 
difference between the groups is not clinically important. 
The app’s impact on symptoms was greatest six weeks after surgery. This coincides 
with the time when symptoms are most likely to be focused on, since previous 
research has shown the first weeks after surgery to be the time when patients with 
pancreatic or periampullary cancer experience most symptoms (Rees et al., 2013). 
This was confirmed by the amount of symptoms reported in the app during the 
first month compared to the following months. Statistically significant decrease 
in symptoms for the patients who used the app was shown for symptoms of pain 
and for gastrointestinal symptoms such as low weight, nausea/vomiting, appetite 
loss, constipation, and flatulence. One of the explanations for this is that advices 
on pain, weight loss and diet were among the most read self-care advice by the 
patients. Surprisingly, there were no statistically significant differences between 
the groups in the symptom diarrhea, known to be dependent of the amount of 
 pancreatic enzymes, even though the advice on pancreatic enzyme supplements 
was the mostly read by the patients using the app. This may reflect that the  control 
group in this study was well informed about management of diarrhea. Also,  diarrhea 
was one of the least experienced symptoms six weeks after surgery in both groups. 
Patients who used the app also reported higher emotional functioning six weeks 
after surgery, which includes questions on feeling tense, worried, irritable and 
depressed. This is consistent with patients using Interaktor during radiotherapy 
for prostate cancer (Sundberg et al., 2017). The impact on these concerns can be 
explained since the patients felt reassured and taken care of at home and could 
get in contact with healthcare when needed. Having symptoms monitored while 
at home and having an easy way to contact nurses have been reported to reduce 
anxiety for patients with cancer (Maguire et al., 2015) and for patients following 
surgery (Dahlberg, Jaensson, Nilsson, Eriksson, & Odencrants, 2018).
Interestingly the level of SOC reported by the patients did not influence how 
they rated their symptoms which indicate a strong support for the app’s effect in 
this group of patients with pancreatic cancer. This is slightly different from what 
Sundberg et al. (2017) found in patients with prostate cancer using the Interaktor 
app, where patients with higher level of SOC mostly rated fewer symptoms, regard-
less if they had used the app or not. 
To reduce symptoms the first weeks after surgery, as done for patients with pan-
creatic cancer using the app, may play and important role to make patients be in 
as good as possible physical and mental condition for adjuvant chemotherapy. 
Receiving and staying on adjuvant chemotherapy is vital for patients with pancre-
atic cancer for increasing survival (Neoptolemos et al., 2004). Hence, it is impor-
tant to continue offering patients the use of the Interaktor app during adjuvant 
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chemotherapy. Previous findings have shown that clinical use of patient-reported 
symptoms makes patients with cancer stay longer on chemotherapy (Basch et al., 
2016). Data on compliance to adjuvant chemotherapy were not collected in this 
thesis. However, previous data from patients at the same hospital undergoing 
chemotherapy showed that patients’ deterioration in many cases caused late cancel-
lations (Fuentes & Frödin, 2015). The authors suggested that the routine monitor-
ing patients’ statuses can be helpful for reducing such late cancellations. Further, 
patients with colorectal cancer have described that to regularly report side-effects 
of chemotherapy, as a source to decision-making of further treatment, is a way to 
participate in care (Drott, Vilhelmsson, Kjellgren, & Berterö, 2016).
8.1.2 Patients’ interest in using the app
For interventions to be meaningful and relevant in clinical care they need to be 
co-created with patients and healthcare professionals (Rose & Bezjak, 2009). The 
involvement of patients and healthcare professionals in Phase I was successful since 
the app later on was perceived to have relevant content with few modification 
suggestions later on. Also, the logged data showed that all symptoms included in 
the app were reported and all self-care advice was viewed.
The patients high adherence to report symptoms daily as intended are comparable 
to results from patients undergoing radiotherapy for prostate cancer using Interaktor 
(Langius-Eklöf et al., 2017). Notable is that some patients using the app follow-
ing PD had 100% adherence, meaning that they used the app to report symptoms 
every day for six months. This confirms that the app was valuable for patients 
to use. In general, high adherence has been reported for patients using different 
kinds of mHealth to support needs related to cancer, independently of the length 
of the reporting period (Richards et al., 2018). The high adherence to using the 
app, even by unexperienced smartphone users, demonstrates that there are no 
reasons not to implement ICT tools based on the argument that patients can have 
difficulties managing technology. On the contrary, smartphone use is increasing 
and now 90 % of Swedish households have access to a smartphone (The Swedish 
Internet Foundation, 2018). During this thesis project, patients have been able to 
borrow a smartphone and in Phase III only two patients needed to do so. It has been 
reported to be essential to allow several training opportunities for patients with less 
technical knowledge, so they can be comfortable in using new systems (Seto et al., 
2012). However, patients using Interaktor only got demonstrations of the app and 
practiced reporting at one supervised occasion. This is a strength, since it reflects 
the reality. When implementing new systems in clinical care, there is seldom time 
for multiple supervised training sessions. Still, only practicing once could have 
affected the drop-out rate and how patients used different components in the app.
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In a Swedish sample of patients with cancer, people who were younger, had a 
partner, and had a higher level of education were more likely to use the Internet 
to search for health information (Mattsson, Olsson, Johansson, & Carlsson, 2017). 
Age-wise this is comparable to patients interested in using the Interaktor app, since 
patients who consented were younger than those who declined. Further, the level of 
education reported by patients using the app are higher than the Swedish popula-
tion with the same age range (Statistics Sweden, 2018). However, these differences 
were seen in the control group as well. The only conclusion drawn from patients 
who declined to participate is that more women than men declined to use the app. 
This is in contrast to previous findings where gender of patients with cancer had 
no association with attitudes towards using eHealth (Jansen et al., 2015). Further, 
amongst the public several studies have found that women are more likely to use 
the Internet for health purposes than men (Andreassen et al., 2007; Carroll et al., 
2017; Nölke, Mensing, Krämer, & Hornberg, 2015).
Some barriers of using mHealth to enhance recovery after surgery have been 
reported by the public, such as concerns of the security and protection of per-
sonal information along with failure of technology (Abelson et al., 2017). Such 
barriers were not brought up by the patients using Interaktor or by patients who 
declined to do so. 
8.1.3 The app as an enabler to person-centered care
The findings in this thesis show that the Interaktor app can enable person-centered 
care, supported by Leplege and colleges (2007) views that person-centered care 
means to involve patients as active partners in care who interacts with healthcare 
professionals. Letting patients report occurrence, frequency, and distress of their 
symptoms to a nurse was a way to lay the ground for the patients’ narrative. A nar-
rative described by Ekman and colleges (2011) as the starting point for the partner-
ship between patients and healthcare professionals. By being called following an 
alert or by sending a message to the nurse through the free-text component, the 
patients could describe and discuss their concerns further. To what extent the fol-
lowing conversation between the patient and the nurse was person-centered are 
not known. However, the patients described how the app enabled them to get their 
voices heard and to raise concerns important to them. 
The findings in this thesis shows that patients monitored at a distance can feel 
safe and cared for, regardless if they were called by a nurse rarely or often, mean-
ing that the reporting and monitoring itself was valuable. This contributes to new 
knowledge on person-centered care since most person-centered care interventions 
have been targeting patients in primary care or hospital setting, and the patients 
narrative have mostly been sought through patient interviews (Olsson, Jakobsson 
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Ung, Swedberg, & Ekman, 2013). Also, previous empirical studies have found that 
for patients to be able to participate in own care the relationship with the nurse is 
fundamental (Angel & Frederiksen, 2015). In contrast, the relationship with the 
nurse did not come up as essential in the interviews with patients using the app. 
Instead, the app itself and that “someone” was monitoring them was described as a 
way to have an extended arm to healthcare. This is useful knowledge in times where 
continuity among nurses, and time to build relationships, is not always achieved.
That the patients using the app felt that they had an extended arm to healthcare can 
be one of the explanations for the impact on symptoms six weeks after  surgery. 
During the first weeks patients in the control group did not have continuous con-
tact with healthcare except for having a name and number to a contact nurse. The 
patients using the app had, above that, timely interactions with their nurse in case 
of alerting symptoms. This could also explain why there were few differences in 
symptoms between the groups six months after surgery. During that time, most 
patients in both groups had weekly contact with nurses since they underwent 
 adjuvant chemotherapy. During those sessions, concerns and symptom manage-
ment could be discussed. However, in a sample of patients with prostate cancer 
who daily meet nurses the findings still showed that the app was effective to reduce 
symptoms at the end of treatment (Sundberg et al., 2017). Also, when analyzing 
symptom changes over time in this thesis, the patients who used the app were more 
stable in symptoms compared to patients who did not use the app. This indicates 
that using the app is valuable also for patients with regular visits to hospital and 
contact with nurses.
For patients to participate in care, shared knowledge and information between 
patients and healthcare professionals have been found to be essential (Angel & 
Frederiksen, 2015; Ekman et al., 2011; Larnebratt et al., 2019). Owing to those 
conclusions the app enables patients to participate in care since they expressed that 
they had learned about own health by conversations with nurses, analyzing their 
own reports and from reading the self-care advice. When interviewing patients 
in the development phases, about self-care advice to manage symptoms, many 
experienced a lack of advice from healthcare at discharge from the hospital. This 
confirms previous finding for this patient group (Andersson et al., 2012; Carey 
et al., 2013) and shows the need to support symptom management. By including 
self-care advice in the Interaktor app, patients had continuous assess to advice to 
manage their symptoms. Having this continuous access to self-care advice was 
described as important since information is easy to forget or cannot always be 
absorbed while at hospital. However, the logged data showed large variety of 
how often self-care advice was read, showing that this was not equally important 
for patients.
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Many of the descriptions from the interviews with patients using the pancreas ver-
sion of Interaktor are consistent with findings in evaluations of other versions of 
Interaktor (Göransson et al., 2018; Hälleberg Nyman et al., 2017) and of similar 
ICT tools where patients report symptoms, are contacted after alerting of  symptoms 
and where they can read self-care advice (Maguire et al., 2015; Weaver et al., 2014). 
Patients interviewed in the aforementioned studies described how they participated 
in their own care by being able to discuss symptoms with nurses, felt in control of 
the situation, learned about their own health, and expressed that it was reassuring 
to have a link to healthcare and not being alone (Göransson et al., 2018; Hälleberg 
Nyman et al., 2017; Maguire et al., 2015; Weaver et al., 2014). Feeling reassured 
by the link to healthcare and being more in control over the recovery process was 
also described by patients who reported symptoms at home after day surgery and 
could choose if they wanted to be contacted by a nurse (Dahlberg et al., 2018). 
It is important to consider the prominent differences in opinions between the patients 
who used the app regarding who should be responsible for initiating contact. Two 
different approaches have been tried in the studies included in this thesis, with 
conflicting findings. While some patients wanted to be the ones initiating contact, 
others felt reassured in knowing that the decision was someone else’s. However, 
one of the important findings is that these patients with pancreatic cancer got help 
with their symptoms when the nurse contacted them following an alert. Patients 
using a similar app have expressed that when the nurse contacted them, and not 
vice versa, they felt less “bothersome” (Weaver et al., 2007). Further, patients with 
different cancer diagnosis have described that they find it hard to by themselves 
estimate the seriousness of their symptoms (Jansen et al., 2015). Considering 
these results, it does not seem responsible to put the responsibility for contacting 
healthcare on patients with such severe symptoms and poor prognosis as patients 
with pancreatic cancer are known to have. Therefore, in future development of 
Interaktor and similar tools, we suggest that the risk assessment model should 
continue to trigger alerts to nurses which they respond to. This could be extended 
to include an easy way for patients to communicate if they do not wish to be con-
tacted and why.
The findings show that the patients used the app’s components in different ways, 
which reflect the app’s intent to offer a support system that address patients’ dif-
ferent supportive care needs. This was also evident since patients made personal 
adjustments when they made arrangements with their nurse over symptoms which 
did not require a call, adjusted their reports when they felt no need for a call, or 
used the free text to leave a comment that a call was not necessary. The reports can 
lay the ground for the care after discharge making it person-centered according to 
the patients’ wishes and needs. Care can then be given in a more timely manner 
instead of solemnly follow a disease-specific schedule.
49
8.2 Discussion of methods
8.2.1 Design and sample 
Using a quasi-experimental design with a historical control group when evaluating 
the intervention has disadvantages since treatment and clinical care can change 
over time. Further, non-randomization can create samples not equal in baseline 
data (Polit & Beck, 2012). However, throughout the whole study period neither 
standard treatment regime nor clinical care routines, such as access to healthcare 
professionals, were changed. This was assured by close contact with the partici-
pating clinics. Further, the two groups did not differ in descriptive data before 
surgery. However, the decline and dropout rate was not comparable between the 
groups (10 % for the control group and 37 % for the intervention group) and more 
women than men declined to use the app. While this affects the generalization 
of the findings, it also gives insight on which patients were interested in using 
mHealth following PD. There were a small number of patients included in the 
evaluation phase. However, the descriptive data shows a variety representative 
for the patient group, and in terms of age the sample is comparable to previous 
descriptions of patients at the same clinic (Noorani, Rangelova, Del Chiaro, Lundell, 
& Ansorge, 2016). Despite the small sample, a moderate to high effect size was 
seen for most outcome variables. The limitation with the design and sample size 
is important to consider and affects the possibility to draw general conclusions of 
the app’s favorable outcomes for patients undergoing pancreaticoduodenectomy. 
Still, for several results in this thesis, other studies report similar findings which 
strengthen our conclusions.
It has been advantageous to use the MRC framework (Craig et al., 2008) for 
achieving the positive results. Involving patients and healthcare professionals 
when creating the content for Interaktor resulted in an app that was perceived 
as relevant and sufficient by the patients who later on used it. By performing a 
small-scale feasibility test we gained insights on who should monitor reports, 
which  necessary adjustment of questions and alerts that needed to be made, and an 
estimated inclusion time could be calculated. However, it is important to keep in 
mind that this thesis does not include all phases of the framework and evaluation 
of costs, healthcare visits, and implementation is yet to be completed.
8.2.2 Questionnaires
One advantage when evaluating the app’s impact on symptoms is the use of well-
validated and reliable instruments. The only EORTC subscale showing low inter-
nal consistency and low inter-item correlation were hepatic symptoms measured 
six weeks after PD. Similar results have been found in a recent psychometric 
analysis of EORTC QLQ-PAN26, concluding that the hepatic subscale has poor 
internal consistency in postoperative patients (Eaton et al., 2017). Looking at the 
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data in the sample included in the thesis, the low internal consistency was due 
to little variation between patients’ values and overall low reported values by 
patients, meaning that most patients did not experience the symptoms included 
in the subscale. Therefore, the low internal consistency of the scale did not affect 
the interpretation of the data.
The ASA-A instrument has not been used previously in a sample of patients 
with pancreatic or periampullary cancer. However, sum scores and analysis of 
internal consistency is comparable to previous validation of the instrument in 
adult patients with chronic diseases managing self-care at home (Fex et al., 2012; 
Sousa, Zauszniewski, Zeller, & Neese, 2008). Owing to the comparable results, 
the ASA-A instrument is a suitable measurement to evaluate self-care activity in 
patients following PD due to cancer. 
The SOC-13 scale has not been used previously in a sample of patients with pan-
creatic or periampullary cancer. Consistent with previous findings, the levels of 
SOC was stable over time (Eriksson & Lindström, 2005; Lindblad et al., 2016). 
Further, the mean levels of SOC are comparable to means of patients with prostate 
cancer using Interaktor during radiotherapy (Sundberg et al., 2017). This shows 
that the SOC-13 scale is a suitable measurement of sense of coherence in this 
patient group.
Missing data from the questionnaires were handled according to the instruments 
recommendations. The amount of missing data within a questionnaire was small 
and considered to be missing at random. Therefore, they were not believed to affect 
the results of the between-group analysis at the different time points (Jakobsen, 
Gluud, Wetterslev, & Winkel, 2017). The only answers considered not to be miss-
ing at random were for questions included in the subscale sexual function, since 
patients often left comments instead of values as a response on those  questions. 
Left out values for sexual function have been reported previously (Eaton et al., 
2017) showing that this is not fully valid questions for this patient group. There 
were some missing questionnaires which are not believed to affect the between-
group analysis at the different time point. However, the amount of missing ASA-A 
questionnaires can affect the within-group analysis since the missing values for 
the ANOVA exceeded 5% (Jakobsen et al., 2017). Therefore, findings of the Inter-
aktor app’s impact on especially self-care activity over time should be confirmed 
in another study.
8.2.3 Logged data
A weakness in the feasibility test is that data on how often patients had viewed 
self-care advice were not logged. However, this was logged in the following 
evaluation. A consistent weakness is that data on how often patients viewed the 
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historical graphs was not logged, which would have been interesting to analyze. 
However, conclusion regarding use of self-care advice and historical graphs can 
be made from the interviews with patients.
8.2.4 Interviews
To establish trustworthiness, the well-known and classic criterion credibility, 
dependability, confirmability and transferability originated by Lincoln and Cuba 
(1985) were considered. To further ensure trustworthiness for the thematic analysis 
Braun and Clarks (2006) 15-point checklist of criteria was followed. 
A potential weakness when creating the content for the app is that no medical social 
worker was interviewed, which might have affected the results especially self-
care advice concerning emotional well-being to be included in the app. Healthcare 
professionals in contact with the patient group during adjuvant chemotherapy 
were not interviewed either. However, five of the interviewed patients had com-
pleted or were undergoing chemotherapy treatment at the time of the interview 
and could give their views on symptoms and self-care strategies during that time. 
Further, when modifying questions and self-care advice in the app for patients 
under going chemotherapy before start of Phase III, care programs and patient 
information were scrutinized.
All participating patients chose the location of the interview. Some preferred to be 
interviewed at the hospital but most were interviewed in their own homes. This can 
affect dependability since the interview situations were not the same. However, 
dependability was ensured by using study specific interview guides. 
The interview with the nurse who participated during the feasibility test was not 
audio recorded and the analyses were made according to the notes taken during 
the interview. This is a weakness, since it affects confirmability of the findings. 
Also, the data was not rich enough for creating categories or getting a deep under-
standing of the nurse’s experiences of caring for patients using an interactive app. 
However, for the purpose of feasibility testing, the findings were considered to be 
enough to make necessary adjustments of the app before start of Phase III. 
Not all interviews in Phase III reached the rich descriptions hoped for, despite 
the use of probing questions (Patton, 2015). This can be due to lacks in the inter-
view guide and to a somewhat inexperienced interviewer. However, as many as 
25 patients were interviewed and several patients are considered to have given 
descriptions rich enough to provide valuable findings.
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9 FUTURE RESEARCH
This thesis does not include all phases in the MRC framework. Full evaluation 
of effects and cost-effectiveness using an RCT and subsequent implementation 
studies are yet to be completed. The findings in Study III can be used to calculate 
sample size for such a RCT. However, to perform a full scale RCT would be time 
consuming or require a multicenter design. Meanwhile, the high adherence to 
report symptoms and the findings from the interviews shows that an interactive 
app like Interaktor is something that patients are interested in, and the question is 
how much more evidence is needed before implementation? It may not be ethical 
to randomize patients who are interested in using mHealth to be involved in care 
to a control group, with the current standard clinical care regime, when we know 
from the results in this study that using the app was highly appreciated and valuable. 
Instead of further evaluation of the pancreas version of Interaktor in an RCT, 
efforts should be made to study the implementation of the app in clinical practice. 
For instance by letting the reported symptoms form the basis of follow-up visits, 
both in terms of when in time visits are best held and what they should concern. 
Also, the reported symptoms could advice on further adjuvant chemotherapy treat-
ment. For this to be feasible, the reports would ideally be transmitted directly to 
the patients’ medical records so that all involved healthcare professionals have 
access to the data.
Further, it would be interesting to find out more about how patients who are not 
interested in using mHealth would like to participate in own care when they are 
discharged. The ideal would be to offer patients different solutions based on their 
own wishes and then study the effects of these interventions.
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10 CONCLUSIONS
• Patients can experience fewer symptoms after discharge following pancrea-
ticoduodenectomy if they regularly reports relevant symptoms and concerns 
via an app to their contact nurse and get support to manage these symptoms.
• The impact on symptoms was highly clinically relevant, indicating that the 
app responds to supportive care needs for patients with pancreatic cancer.
• To let patients report symptoms or write messages to nurses can be a way 
to enable the patients narrative, and thereby form a partnership necessary 
to create care planned according to patients’ wishes and needs, and not only 
by predefined disease-specific standard care schedules.
• Monitoring patients at a distance and offering them an extended arm to 
healthcare can make them feel reassured and taken cared of at home.
• To offer a system where the nurse is responsible to contact the patient 
for alerting symptoms, and not vise versa, is effective to achieve timely 
symptom management.
• Patients can learn about their own health by having easy access to self-care 
advice and by analyzing their daily symptoms.
• To offer an app with multiple components enables patients to use the app 
according to their individual needs.
• To co-create the content in interventions together with patients and health-
care professionals is advantageously to get a relevant and valuable content.
• Not all patients are interested in using an app like Interaktor. However, 
patients who are interested have high adherence and find it valuable and 
easy to use. 
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11 SVENSK SAMMANFATTNING  
(SUMMERY IN SWEDISH)
Bakgrund
Patienter med pankreas- eller periampullär cancer har dålig prognos även efter 
kurativt syftande kirurgi. Den vanligaste operationen är pankreatikoduodenektomi 
som ofta resulterar i svåra symtom och försämrad livskvalitet under lång tid 
efteråt. Patienterna har ofta otillräcklig kunskap och stöd för att kunna hantera 
sina symtom. För att möta patienters behov behövs en mer personcentrerad vård 
som utgår från varje patients behov och för detta krävs ett partnerskap mellan 
patienter och vårdpersonal. Rutinmässig insamling och hantering av symtom med 
stöd av mHälso-verktyg har visat sig kunna förbättra hälsorelaterad livskvalitet 
och minska symtom för patienter med cancer. 
Syfte
Att utvärdera om insamling och hantering av patientrapporterade utfallsmått i kli-
nisk vård, med stöd av en interaktiv app (Interaktor), kan främja personcentrerad 
vård och förbättra utfall för patienter som genomgått pankreatikoduodenektomi 
p.g.a. cancer.
Interaktor
Genom Interaktor rapporterar patienten symptom till sin kontaktsjuksköterska 
genom att svara på frågor om olika symptoms förekomst, frekvens och besvärsgrad. 
Vid alarmerande symptom ringer kontaktsjuksköterskan upp patienten för att ge 
råd eller annat stöd. I appen kan patienten även se grafer över sina rapporterade 
symtom samt läsa egenvårdsråd för symtomhantering.
Metod
Ett ramverk för komplexa interventioner, utarbetat av Medicinska Forskningsrådet 
i Storbritannien, användes för att utveckla och utvärdera appen. Detta gjordes 
genom tre faser. I Fas I utvecklades innehållet i appen genom intervjuer med 
patienter (n=14) och vårdpersonal (n= 10). I Fas II gjordes ett genomförbarhetstest 
då  patienter (n=6) använde appen under en månad. I Fas III utvärderades appen 
genom att analysera dess påverkan på symtom och egenvårdsaktivitet hos patienter 
(n=26) som använt appen under sex månader jämfört med en historisk kontrollgrupp 
av patienter (n=33) som inte använt appen, genom analys av patienters (n=26) 
 loggad data i appen och genom intervjuer med patienter (n=25) som använt appen.
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Resultat 
Resultaten i Fas I visade att patienter efter operationen ofta upplevde ätsvårigheter, 
tarmbesvär, trötthet, smärta samt oro. Patienterna upplevde brister i informationen 
och råd om framför allt hantering av läkemedel med konstgjort bukspott samt 
nedtrappning av smärtlindring. Vårdpersonalen beskrev att de ofta gav patienterna 
råd men att patienterna ofta hade svårt att ta till sig all information som gavs. 
Resultaten bidrog till kunskap om vilka symtom som är viktiga att bedöma närmsta 
månaderna efter pankreatikoduodenektomi och några egenvårdsråd och strategier 
för att hantera dessa symtom. Detta formade sedan innehållet i appen. 
Resultaten i Fas II visade god genomförbarhet och att appen hade relevant innehåll. 
Patienterna kände sig trygga och omhändertagna i hemmet och fick stöd att hantera 
sina symtom. Efter att några frågor och larm i appen justerats startades nästa fas.
Resultaten i Fas III visade att patienter som använde appen upplevde färre sym-
tom och hade högre egenvårdsaktivitet efter pankreatikoduodenektomi jämfört 
med kontrollgruppen som inte använt appen. Patienterna som använde appen hade 
hög följsamhet till att rapportera symtom och kände att de genom appen fick sin 
röst hörd, att de hade en förlängd arm till sjukvården och att de lärde sig om sin 
egen hälsa. 
Slutsats
Avhandlingen visar en interaktiv app som Interaktor kan stödja patienter med 
svåra symtom och dålig prognos. Att monitorera patienter när de befinner sig i 
hemmet kan få dem att känna sig trygga och omhändertagna. Patienter kan lära 
sig om sin egen hälsa genom att ha enkel tillgång till egenvårdsråd och genom att 
analysera sina dagliga symtom. Personcentrerad vård kan främjas genom att göra 
patienter till aktiva partners i vården och genom att i rätt tid identifiera symtom 
som är viktiga för dem. Interaktor kan bidra till att utveckla vården till att vara 
anpassad till patienters individuella behov och inte enbart följa ett förutbestämt 
sjukdomsspecifikt vårdprogram. Alla patienter är inte intresserade av att använda 
mHälsa men de som är det har hög följsamhet och tycker det är värdefullt och 
enkelt att använda.
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